MetaADEDB 2.0 @ LMMD
Fingolimod Hydrochloride
(SWZTYAVBMYWFGS-UHFFFAOYSA-N)
Structure
SMILES
CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N.Cl
Molecular Formula:
C19H34ClNO2
Molecular Weight:
343.932
Log P:
4.7066
Hydrogen Bond Acceptor:
3
Hydrogen Bond Donor:
4
TPSA:
66.48
CAS Number(s):
162359-56-0; 1346604-90-7
Synonym(s)
1.
Fingolimod Hydrochloride
2.
2-Amino-2-(2-(4-octylphenyl)ethyl)-1,3-propanediol hydrochloride
3.
FTY 720
4.
FTY-720
5.
FTY720
6.
Fingolimod
7.
Gilenia
8.
Gilenya
9.
Hydrochloride, Fingolimod
External Link(s)
MeSHD000068876
PubChem Compound11824109
107969
57516011
BindingDB50360523
ChEBI63112
CHEMBLCHEMBL544665
KEGGdr:D04187
Therapeutic Target DatabaseD0HI1K
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1FatigueFAERS: 5771
Canada Vigilance: 225
Canada Vigilance
SIDER
US FAERS
2HeadacheFAERS: 3974
Canada Vigilance: 165
Canada Vigilance
SIDER
US FAERS
3Multiple sclerosis relapseFAERS: 3823
Canada Vigilance: 422
Canada Vigilance
SIDER
US FAERS
4DizzinessFAERS: 2824
Canada Vigilance: 126
Canada Vigilance
SIDER
US FAERS
5White blood cell count decreasedFAERS: 2457
Canada Vigilance: 109
Canada Vigilance
US FAERS
6Lymphocyte count decreasedFAERS: 2160
Canada Vigilance: 158
Canada Vigilance
US FAERS
7NauseaFAERS: 1907
Canada Vigilance: 83
Canada Vigilance
US FAERS
8MalaiseFAERS: 1797
Canada Vigilance: 54
Canada Vigilance
US FAERS
9Central nervous system lesionFAERS: 1657
Canada Vigilance: 88
Canada Vigilance
US FAERS
10Memory impairmentFAERS: 1536
Canada Vigilance: 26
Canada Vigilance
US FAERS
11Visual ImpairmentFAERS: 1428
Canada Vigilance: 76
Canada Vigilance
US FAERS
12PainFAERS: 1385
Canada Vigilance: 30
Canada Vigilance
US FAERS
13AstheniaFAERS: 1331
Canada Vigilance: 44
Canada Vigilance
SIDER
US FAERS
14Back PainFAERS: 1303
Canada Vigilance: 58
Canada Vigilance
SIDER
US FAERS
15Feeling abnormalFAERS: 1178
Canada Vigilance: 27
Canada Vigilance
US FAERS
16NasopharyngitisFAERS: 1144
Canada Vigilance: 72
Canada Vigilance
US FAERS
17Drug ineffectiveFAERS: 1097
Canada Vigilance: 164
Canada Vigilance
US FAERS
18SomnolenceFAERS: 944
Canada Vigilance: 22
Canada Vigilance
US FAERS
19Alanine Aminotransferase IncreasedFAERS: 890
Canada Vigilance: 21
Canada Vigilance
SIDER
US FAERS
20Chest PainFAERS: 810
Canada Vigilance: 36
Canada Vigilance
US FAERS
21Maternal exposure during pregnancyFAERS: 763
Canada Vigilance: 13
Canada Vigilance
US FAERS
22BradycardiaFAERS: 749
Canada Vigilance: 48
18218783CTD
SIDER
Canada Vigilance
US FAERS
23Urinary tract infectionFAERS: 742
Canada Vigilance: 40
Canada Vigilance
US FAERS
24AnxietyFAERS: 730
Canada Vigilance: 34
Canada Vigilance
US FAERS
25VomitingFAERS: 724
Canada Vigilance: 33
Canada Vigilance
US FAERS
26Prescribed underdoseFAERS: 722
Canada Vigilance: 57
Canada Vigilance
US FAERS
27AlopeciaFAERS: 687
Canada Vigilance: 25
Canada Vigilance
SIDER
US FAERS
28LymphopeniaFAERS: 678
Canada Vigilance: 25
Canada Vigilance
SIDER
US FAERS
29Multiple SclerosisFAERS: 651
Canada Vigilance: 47
25223691CTD
Canada Vigilance
US FAERS
30ArthralgiaFAERS: 641
Canada Vigilance: 24
Canada Vigilance
US FAERS
31Oropharyngeal painFAERS: 641
Canada Vigilance: 25
Canada Vigilance
US FAERS
32PalpitationsFAERS: 637
Canada Vigilance: 33
Canada Vigilance
SIDER
US FAERS
33Chest discomfortFAERS: 599
Canada Vigilance: 30
Canada Vigilance
US FAERS
34TremorFAERS: 587
Canada Vigilance: 21
Canada Vigilance
US FAERS
35StressFAERS: 556
Canada Vigilance: 28
Canada Vigilance
US FAERS
36Weight decreasedFAERS: 530
Canada Vigilance: 16
Canada Vigilance
SIDER
US FAERS
37SinusitisFAERS: 521
Canada Vigilance: 23
Canada Vigilance
SIDER
US FAERS
38Aspartate Aminotransferase IncreasedFAERS: 489
Canada Vigilance: 12
Canada Vigilance
SIDER
US FAERS
39InfluenzaFAERS: 465
Canada Vigilance: 21
Canada Vigilance
SIDER
US FAERS
40Abdominal discomfortFAERS: 453
Canada Vigilance: 13
Canada Vigilance
US FAERS
41Eye painFAERS: 429
Canada Vigilance: 38
Canada Vigilance
SIDER
US FAERS
42Limb discomfortFAERS: 422
Canada Vigilance: 24
Canada Vigilance
US FAERS
43Musculoskeletal stiffnessFAERS: 411
Canada Vigilance: 17
Canada Vigilance
US FAERS
44VertigoFAERS: 405
Canada Vigilance: 28
Canada Vigilance
US FAERS
45PruritusFAERS: 399
Canada Vigilance: 23
Canada Vigilance
SIDER
US FAERS
46Optic NeuritisFAERS: 361
Canada Vigilance: 33
Canada Vigilance
US FAERS
47Abdominal PainFAERS: 330
Canada Vigilance: 21
Canada Vigilance
US FAERS
48AmnesiaFAERS: 318
Canada Vigilance: 3
Canada Vigilance
US FAERS
49LeukopeniaFAERS: 308
Canada Vigilance: 9
Canada Vigilance
SIDER
US FAERS
50Gamma-Glutamyltransferase IncreasedFAERS: 307
Canada Vigilance: 7
Canada Vigilance
SIDER
US FAERS
51Blood alkaline phosphatase increasedFAERS: 306
Canada Vigilance: 2
Canada Vigilance
US FAERS
52PneumoniaFAERS: 304
Canada Vigilance: 44
Canada Vigilance
SIDER
US FAERS
53Concomitant disease aggravatedFAERS: 294
Canada Vigilance: 15
Canada Vigilance
US FAERS
54Depressed moodFAERS: 290
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
55ConstipationFAERS: 289
Canada Vigilance: 11
Canada Vigilance
US FAERS
56BronchitisFAERS: 286
Canada Vigilance: 34
Canada Vigilance
SIDER
US FAERS
57HypotensionFAERS: 282
Canada Vigilance: 9
Canada Vigilance
SIDER
US FAERS
58Neck PainFAERS: 277
Canada Vigilance: 18
Canada Vigilance
US FAERS
59Expanded disability status scale score increasedFAERS: 275
Canada Vigilance: 172
Canada Vigilance
US FAERS
60HypersensitivityFAERS: 275
Canada Vigilance: 7
Canada Vigilance
US FAERS
61HemiparesisFAERS: 265
Canada Vigilance: 18
Canada Vigilance
US FAERS
62ChillsFAERS: 263
Canada Vigilance: 14
Canada Vigilance
US FAERS
63DiplopiaFAERS: 261
Canada Vigilance: 15
Canada Vigilance
US FAERS
64InfectionFAERS: 256
Canada Vigilance: 10
Canada Vigilance
SIDER
US FAERS
65Burning sensationFAERS: 250
Canada Vigilance: 16
Canada Vigilance
US FAERS
66SyncopeFAERS: 247
Canada Vigilance: 10
Canada Vigilance
US FAERS
67Sinus bradycardiaFAERS: 244
Canada Vigilance: 45
Canada Vigilance
US FAERS
68General physical health deteriorationFAERS: 242
Canada Vigilance: 14
Canada Vigilance
US FAERS
69Inappropriate schedule of drug administrationFAERS: 241US FAERS
70DysarthriaFAERS: 232
Canada Vigilance: 13
Canada Vigilance
US FAERS
71Peripheral swellingFAERS: 222
Canada Vigilance: 13
Canada Vigilance
US FAERS
72Musculoskeletal PainFAERS: 220
Canada Vigilance: 11
Canada Vigilance
US FAERS
73DyspepsiaFAERS: 218
Canada Vigilance: 11
Canada Vigilance
US FAERS
74Blood cholesterol increasedFAERS: 215
Canada Vigilance: 10
Canada Vigilance
US FAERS
75MyalgiaFAERS: 215
Canada Vigilance: 7
Canada Vigilance
US FAERS
76NervousnessFAERS: 210
Canada Vigilance: 4
Canada Vigilance
US FAERS
77Muscle SpasticityFAERS: 203
Canada Vigilance: 10
Canada Vigilance
US FAERS
78Basal cell carcinomaFAERS: 202
Canada Vigilance: 8
Canada Vigilance
US FAERS
79ErythemaFAERS: 196
Canada Vigilance: 21
Canada Vigilance
US FAERS
80DysgeusiaFAERS: 193
Canada Vigilance: 9
Canada Vigilance
US FAERS
81Rebound effectFAERS: 191
Canada Vigilance: 5
Canada Vigilance
US FAERS
82FlushingFAERS: 190
Canada Vigilance: 8
Canada Vigilance
US FAERS
83BlindnessFAERS: 183
Canada Vigilance: 5
Canada Vigilance
US FAERS
84AphasiaFAERS: 179
Canada Vigilance: 6
Canada Vigilance
US FAERS
85No adverse eventFAERS: 179US FAERS
86Cerebrovascular accidentFAERS: 177
Canada Vigilance: 6
Canada Vigilance
SIDER
US FAERS
87Myocardial InfarctionFAERS: 172
Canada Vigilance: 7
Canada Vigilance
US FAERS
88PhotophobiaFAERS: 170
Canada Vigilance: 9
Canada Vigilance
US FAERS
89JC virus test positiveFAERS: 168US FAERS
90Disease recurrenceFAERS: 167
Canada Vigilance: 24
Canada Vigilance
US FAERS
91NeutropeniaFAERS: 165
Canada Vigilance: 11
Canada Vigilance
US FAERS
92DysgraphiaFAERS: 162
Canada Vigilance: 4
Canada Vigilance
US FAERS
93Skin lesionFAERS: 162
Canada Vigilance: 13
Canada Vigilance
US FAERS
94Maternal exposure timing unspecifiedFAERS: 161
Canada Vigilance: 2
Canada Vigilance
US FAERS
95Temperature intoleranceFAERS: 158
Canada Vigilance: 3
Canada Vigilance
US FAERS
96Urinary IncontinenceFAERS: 157
Canada Vigilance: 6
Canada Vigilance
US FAERS
97UrticariaFAERS: 157
Canada Vigilance: 3
Canada Vigilance
US FAERS
98DehydrationFAERS: 155
Canada Vigilance: 2
Canada Vigilance
US FAERS
99Drug monitoring procedure not performedFAERS: 155
Canada Vigilance: 2
Canada Vigilance
US FAERS
100Electrocardiogram abnormalFAERS: 154
Canada Vigilance: 9
Canada Vigilance
US FAERS
101Drug dose omissionFAERS: 148US FAERS
102NeuralgiaFAERS: 148
Canada Vigilance: 6
Canada Vigilance
US FAERS
103AbasiaFAERS: 147US FAERS
104AtaxiaFAERS: 145
Canada Vigilance: 11
Canada Vigilance
US FAERS
105Joint swellingFAERS: 141
Canada Vigilance: 7
Canada Vigilance
US FAERS
106CystitisFAERS: 138
Canada Vigilance: 18
Canada Vigilance
US FAERS
107Feeling ColdFAERS: 124
Canada Vigilance: 10
Canada Vigilance
US FAERS
108AcneFAERS: 123
Canada Vigilance: 13
Canada Vigilance
US FAERS
109Maternal exposure before pregnancyFAERS: 123
Canada Vigilance: 5
Canada Vigilance
US FAERS
110SwellingFAERS: 122
Canada Vigilance: 8
Canada Vigilance
US FAERS
111Neutrophil count decreasedFAERS: 121
Canada Vigilance: 9
Canada Vigilance
SIDER
US FAERS
112Head discomfortFAERS: 118
Canada Vigilance: 5
Canada Vigilance
US FAERS
113EpilepsyFAERS: 117
Canada Vigilance: 1
Canada Vigilance
US FAERS
114CryingFAERS: 113
Canada Vigilance: 5
Canada Vigilance
US FAERS
115AsthmaFAERS: 112
Canada Vigilance: 5
Canada Vigilance
US FAERS
116TinnitusFAERS: 112
Canada Vigilance: 4
Canada Vigilance
US FAERS
117Blood glucose increasedFAERS: 111
Canada Vigilance: 1
Canada Vigilance
US FAERS
118CataractFAERS: 111
Canada Vigilance: 2
Canada Vigilance
US FAERS
119TachycardiaFAERS: 110
Canada Vigilance: 1
Canada Vigilance
US FAERS
120DysuriaFAERS: 108
Canada Vigilance: 6
Canada Vigilance
US FAERS
121Extra dose administeredFAERS: 108
Canada Vigilance: 11
Canada Vigilance
US FAERS
122HypokinesiaFAERS: 108
Canada Vigilance: 2
Canada Vigilance
US FAERS
123DiscomfortFAERS: 106
Canada Vigilance: 6
Canada Vigilance
US FAERS
124Low density lipoprotein increasedFAERS: 106
Canada Vigilance: 6
Canada Vigilance
US FAERS
125NephrolithiasisFAERS: 106
Canada Vigilance: 7
Canada Vigilance
US FAERS
126LethargyFAERS: 104US FAERS
127Vitreous floatersFAERS: 104
Canada Vigilance: 2
Canada Vigilance
US FAERS
128Blood pressure fluctuationFAERS: 102
Canada Vigilance: 11
Canada Vigilance
US FAERS
129DysphoniaFAERS: 102
Canada Vigilance: 2
Canada Vigilance
US FAERS
130Angina PectorisFAERS: 99
Canada Vigilance: 7
Canada Vigilance
US FAERS
131Atrial FibrillationFAERS: 95
Canada Vigilance: 1
Canada Vigilance
US FAERS
132Vitamin D DeficiencyFAERS: 95
Canada Vigilance: 1
Canada Vigilance
US FAERS
133OverdoseFAERS: 93US FAERS
134Drug administered to patient of inappropriate ageFAERS: 92US FAERS
135Muscle tightnessFAERS: 92
Canada Vigilance: 2
Canada Vigilance
US FAERS
136EpistaxisFAERS: 90
Canada Vigilance: 3
Canada Vigilance
US FAERS
137JC polyomavirus test positiveFAERS: 90
Canada Vigilance: 3
Canada Vigilance
US FAERS
138Lymphocyte count increasedFAERS: 89
Canada Vigilance: 2
Canada Vigilance
US FAERS
139CellulitisFAERS: 87
Canada Vigilance: 5
Canada Vigilance
US FAERS
140Ocular discomfortFAERS: 86
Canada Vigilance: 5
Canada Vigilance
US FAERS
141Productive CoughFAERS: 86
Canada Vigilance: 10
Canada Vigilance
US FAERS
142Transaminases increasedFAERS: 85
Canada Vigilance: 1
Canada Vigilance
US FAERS
143Accidental overdoseFAERS: 84
Canada Vigilance: 7
Canada Vigilance
US FAERS
144CD4 Lymphocytes DecreasedFAERS: 84
Canada Vigilance: 2
Canada Vigilance
US FAERS
145Product use in unapproved indicationFAERS: 84
Canada Vigilance: 2
Canada Vigilance
US FAERS
146Gait inabilityFAERS: 83
Canada Vigilance: 6
Canada Vigilance
US FAERS
147LymphadenopathyFAERS: 83
Canada Vigilance: 7
Canada Vigilance
US FAERS
148Diabetes MellitusFAERS: 82
Canada Vigilance: 5
Canada Vigilance
US FAERS
149InflammationFAERS: 82US FAERS
150ChromaturiaFAERS: 81
Canada Vigilance: 4
Canada Vigilance
US FAERS
151GlaucomaFAERS: 81
Canada Vigilance: 5
Canada Vigilance
US FAERS
152ArthritisFAERS: 80
Canada Vigilance: 1
Canada Vigilance
US FAERS
153Dry skinFAERS: 80
Canada Vigilance: 6
Canada Vigilance
US FAERS
154FlatulenceFAERS: 79
Canada Vigilance: 3
Canada Vigilance
US FAERS
155Blood alkaline phosphatase decreasedFAERS: 78
Canada Vigilance: 1
Canada Vigilance
US FAERS
156Decreased immune responsivenessFAERS: 78
Canada Vigilance: 2
Canada Vigilance
US FAERS
157Trigeminal NeuralgiaFAERS: 78
Canada Vigilance: 2
Canada Vigilance
US FAERS
158DisorientationFAERS: 77
Canada Vigilance: 2
Canada Vigilance
US FAERS
159High density lipoprotein increasedFAERS: 77US FAERS
160Urinary RetentionFAERS: 77
Canada Vigilance: 5
Canada Vigilance
US FAERS
161treatment failureFAERS: 77
Canada Vigilance: 4
Canada Vigilance
US FAERS
162IncontinenceFAERS: 76
Canada Vigilance: 4
Canada Vigilance
US FAERS
163Emotional disorderFAERS: 75
Canada Vigilance: 3
Canada Vigilance
US FAERS
164HypersomniaFAERS: 75
Canada Vigilance: 2
Canada Vigilance
US FAERS
165SepsisFAERS: 75
Canada Vigilance: 1
Canada Vigilance
US FAERS
166LentigoFAERS: 74
Canada Vigilance: 1
Canada Vigilance
US FAERS
167Throat irritationFAERS: 74
Canada Vigilance: 2
Canada Vigilance
US FAERS
168PsoriasisFAERS: 73
Canada Vigilance: 2
Canada Vigilance
US FAERS
169nervous system disorderFAERS: 73
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
170Restless Legs SyndromeFAERS: 72
Canada Vigilance: 1
Canada Vigilance
US FAERS
171Feeling jitteryFAERS: 71US FAERS
172Night sweatsFAERS: 71
Canada Vigilance: 3
Canada Vigilance
US FAERS
173Limb injuryFAERS: 70
Canada Vigilance: 3
Canada Vigilance
US FAERS
174Squamous cell carcinomaFAERS: 70
Canada Vigilance: 1
Canada Vigilance
US FAERS
175Facial PainFAERS: 69
Canada Vigilance: 3
Canada Vigilance
US FAERS
176Ankle FractureFAERS: 66
Canada Vigilance: 5
Canada Vigilance
US FAERS
177SluggishnessFAERS: 65
Canada Vigilance: 1
Canada Vigilance
US FAERS
178ThrombosisFAERS: 65
Canada Vigilance: 2
Canada Vigilance
US FAERS
179Disease ProgressionFAERS: 64
Canada Vigilance: 8
Canada Vigilance
US FAERS
180Eye irritationFAERS: 64
Canada Vigilance: 5
Canada Vigilance
US FAERS
181Frustration tolerance decreasedFAERS: 64
Canada Vigilance: 2
Canada Vigilance
US FAERS
182Joint injuryFAERS: 64
Canada Vigilance: 2
Canada Vigilance
US FAERS
183PresyncopeFAERS: 64
Canada Vigilance: 3
Canada Vigilance
US FAERS
184Mood swingsFAERS: 63
Canada Vigilance: 1
Canada Vigilance
US FAERS
185Musculoskeletal discomfortFAERS: 63
Canada Vigilance: 1
Canada Vigilance
US FAERS
186Skin PapillomaFAERS: 63
Canada Vigilance: 4
Canada Vigilance
US FAERS
187AsthenopiaFAERS: 62
Canada Vigilance: 5
Canada Vigilance
US FAERS
188EczemaFAERS: 60
Canada Vigilance: 8
Canada Vigilance
SIDER
US FAERS
189Inappropriate schedule of product administrationFAERS: 60
Canada Vigilance: 18
Canada Vigilance
US FAERS
190Macular degenerationFAERS: 60
Canada Vigilance: 2
Canada Vigilance
US FAERS
191Cerebral disorderFAERS: 59US FAERS
192Mental impairmentFAERS: 58
Canada Vigilance: 1
Canada Vigilance
US FAERS
193ThrombocytopeniaFAERS: 58
Canada Vigilance: 2
Canada Vigilance
US FAERS
194Cervical dysplasiaFAERS: 57
Canada Vigilance: 3
Canada Vigilance
US FAERS
195CholelithiasisFAERS: 56
Canada Vigilance: 7
Canada Vigilance
US FAERS
196Solar lentigoFAERS: 56US FAERS
197Viral upper respiratory tract infectionFAERS: 56
Canada Vigilance: 1
Canada Vigilance
US FAERS
198Monocyte count increasedFAERS: 55
Canada Vigilance: 1
Canada Vigilance
US FAERS
199AphoniaFAERS: 54
Canada Vigilance: 5
Canada Vigilance
US FAERS
200Atrioventricular BlockFAERS: 54
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
201Band sensationFAERS: 54US FAERS
202Musculoskeletal chest painFAERS: 54
Canada Vigilance: 2
Canada Vigilance
US FAERS
203AngerFAERS: 53
Canada Vigilance: 2
Canada Vigilance
US FAERS
204Carpal Tunnel SyndromeFAERS: 53
Canada Vigilance: 3
Canada Vigilance
US FAERS
205GastroenteritisFAERS: 53
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
206Joint stiffnessFAERS: 52
Canada Vigilance: 4
Canada Vigilance
US FAERS
207Muscle RigidityFAERS: 52
Canada Vigilance: 1
Canada Vigilance
US FAERS
208Pulmonary EmbolismFAERS: 52
Canada Vigilance: 3
Canada Vigilance
US FAERS
209SneezingFAERS: 52
Canada Vigilance: 4
Canada Vigilance
US FAERS
210Cervix carcinomaFAERS: 51
Canada Vigilance: 3
Canada Vigilance
US FAERS
211Full blood count decreasedFAERS: 51
Canada Vigilance: 2
Canada Vigilance
US FAERS
212Suicide attemptFAERS: 51
Canada Vigilance: 2
Canada Vigilance
US FAERS
213WheezingFAERS: 51
Canada Vigilance: 1
Canada Vigilance
US FAERS
214LaryngitisFAERS: 50
Canada Vigilance: 2
Canada Vigilance
US FAERS
215Lower respiratory tract infectionFAERS: 50
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
216StomatitisFAERS: 50
Canada Vigilance: 1
Canada Vigilance
US FAERS
217Blood potassium decreasedFAERS: 49
Canada Vigilance: 2
Canada Vigilance
US FAERS
218Exposure via fatherFAERS: 49US FAERS
219Status EpilepticusFAERS: 48
Canada Vigilance: 1
Canada Vigilance
US FAERS
220UveitisFAERS: 48
Canada Vigilance: 1
Canada Vigilance
US FAERS
221BlepharospasmFAERS: 47
Canada Vigilance: 2
Canada Vigilance
US FAERS
222Cardiac FlutterFAERS: 47
Canada Vigilance: 5
Canada Vigilance
US FAERS
223Cold sweatFAERS: 47
Canada Vigilance: 2
Canada Vigilance
US FAERS
224Immune Reconstitution Inflammatory SyndromeFAERS: 47
Canada Vigilance: 2
Canada Vigilance
US FAERS
225Muscle strainFAERS: 47
Canada Vigilance: 2
Canada Vigilance
US FAERS
226Progressive multiple sclerosisFAERS: 47
Canada Vigilance: 3
Canada Vigilance
US FAERS
227Uhthoff's phenomenonFAERS: 47
Canada Vigilance: 1
Canada Vigilance
US FAERS
228AgitationFAERS: 46
Canada Vigilance: 1
Canada Vigilance
US FAERS
229Blood count abnormalFAERS: 46
Canada Vigilance: 1
Canada Vigilance
US FAERS
230NystagmusFAERS: 46
Canada Vigilance: 2
Canada Vigilance
US FAERS
231Poor quality sleepFAERS: 46
Canada Vigilance: 1
Canada Vigilance
US FAERS
232DeafnessFAERS: 45
Canada Vigilance: 2
Canada Vigilance
US FAERS
233Incorrect dose administeredFAERS: 45
Canada Vigilance: 1
Canada Vigilance
US FAERS
234PapuleFAERS: 45
Canada Vigilance: 2
Canada Vigilance
US FAERS
235ThirstFAERS: 45
Canada Vigilance: 2
Canada Vigilance
US FAERS
236FibromyalgiaFAERS: 44
Canada Vigilance: 1
Canada Vigilance
US FAERS
237MenorrhagiaFAERS: 44
Canada Vigilance: 4
Canada Vigilance
US FAERS
238Squamous cell carcinoma of skinFAERS: 44
Canada Vigilance: 1
Canada Vigilance
US FAERS
239ConjunctivitisFAERS: 43
Canada Vigilance: 3
Canada Vigilance
US FAERS
240ImmunosuppressionFAERS: 43
Canada Vigilance: 1
Canada Vigilance
US FAERS
241Therapeutic response unexpectedFAERS: 43US FAERS
242DementiaFAERS: 42
Canada Vigilance: 1
Canada Vigilance
US FAERS
243Ear discomfortFAERS: 42
Canada Vigilance: 2
Canada Vigilance
US FAERS
244HemiplegiaFAERS: 42US FAERS
245Oral painFAERS: 42
Canada Vigilance: 1
Canada Vigilance
US FAERS
246Bone painFAERS: 41
Canada Vigilance: 2
Canada Vigilance
US FAERS
247HepatitisFAERS: 41
Canada Vigilance: 1
Canada Vigilance
US FAERS
248Tumefactive multiple sclerosisFAERS: 41
Canada Vigilance: 1
Canada Vigilance
US FAERS
249Invasive Ductal Breast CarcinomaFAERS: 40US FAERS
250Lymphocyte percentage decreasedFAERS: 40
Canada Vigilance: 6
Canada Vigilance
US FAERS
251ToothacheFAERS: 40
Canada Vigilance: 6
Canada Vigilance
US FAERS
252Blood triglycerides increasedFAERS: 39
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
253HungerFAERS: 39US FAERS
254PancreatitisFAERS: 39
Canada Vigilance: 2
Canada Vigilance
US FAERS
255ParaparesisFAERS: 39
Canada Vigilance: 3
Canada Vigilance
US FAERS
256CystFAERS: 38
Canada Vigilance: 4
Canada Vigilance
US FAERS
257DemyelinationFAERS: 38
Canada Vigilance: 2
Canada Vigilance
US FAERS
258Facial paralysisFAERS: 38
Canada Vigilance: 3
Canada Vigilance
US FAERS
259Rash erythematousFAERS: 38
Canada Vigilance: 4
Canada Vigilance
US FAERS
260Blood bilirubin decreasedFAERS: 37US FAERS
261ChokingFAERS: 37US FAERS
262Emotional distressFAERS: 37
Canada Vigilance: 1
Canada Vigilance
US FAERS
263Immune thrombocytopenic purpuraFAERS: 37
Canada Vigilance: 5
Canada Vigilance
US FAERS
264Alanine aminotransferase decreasedFAERS: 36
Canada Vigilance: 2
Canada Vigilance
US FAERS
265Sinus ArrhythmiaFAERS: 36
Canada Vigilance: 11
Canada Vigilance
US FAERS
266Actinic keratosisFAERS: 35US FAERS
267AppendicitisFAERS: 35
Canada Vigilance: 3
Canada Vigilance
US FAERS
268Blood glucose decreasedFAERS: 35US FAERS
269Cerebral atrophyFAERS: 35
Canada Vigilance: 4
Canada Vigilance
US FAERS
270MonoplegiaFAERS: 35
Canada Vigilance: 3
Canada Vigilance
US FAERS
271RosaceaFAERS: 35
Canada Vigilance: 1
Canada Vigilance
US FAERS
272SciaticaFAERS: 35
Canada Vigilance: 1
Canada Vigilance
US FAERS
273Blood urine presentFAERS: 34
Canada Vigilance: 2
Canada Vigilance
US FAERS
274Eye InfectionFAERS: 34
Canada Vigilance: 4
Canada Vigilance
US FAERS
275Non-cardiac chest painFAERS: 34
Canada Vigilance: 1
Canada Vigilance
US FAERS
276VIIth nerve paralysisFAERS: 34US FAERS
277White blood cell count abnormalFAERS: 34
Canada Vigilance: 2
Canada Vigilance
US FAERS
278ArthropathyFAERS: 33
Canada Vigilance: 3
Canada Vigilance
US FAERS
279GastritisFAERS: 33US FAERS
280Lymphocyte count abnormalFAERS: 33US FAERS
281PallorFAERS: 33
Canada Vigilance: 3
Canada Vigilance
US FAERS
282Electroencephalogram abnormalFAERS: 32US FAERS
283Irritable Bowel SyndromeFAERS: 32
Canada Vigilance: 1
Canada Vigilance
US FAERS
284LacerationFAERS: 32US FAERS
285ParesisFAERS: 32
Canada Vigilance: 5
Canada Vigilance
US FAERS
286Drug monitoring procedure incorrectly performedFAERS: 31US FAERS
287Food PoisoningFAERS: 31
Canada Vigilance: 3
Canada Vigilance
US FAERS
288Migraine with AuraFAERS: 31
Canada Vigilance: 2
Canada Vigilance
US FAERS
289Pulmonary congestionFAERS: 31US FAERS
290Blood urea increasedFAERS: 30US FAERS
291ClumsinessFAERS: 30
Canada Vigilance: 1
Canada Vigilance
US FAERS
292DermatitisFAERS: 30
Canada Vigilance: 1
Canada Vigilance
US FAERS
293Drug administration errorFAERS: 30US FAERS
294DysphemiaFAERS: 30US FAERS
295Flank PainFAERS: 30
Canada Vigilance: 1
Canada Vigilance
US FAERS
296Grip strength decreasedFAERS: 30
Canada Vigilance: 1
Canada Vigilance
US FAERS
297HypothyroidismFAERS: 30
Canada Vigilance: 3
Canada Vigilance
US FAERS
298Personality ChangeFAERS: 30US FAERS
299Retinal DetachmentFAERS: 30
Canada Vigilance: 2
Canada Vigilance
US FAERS
300Back disorderFAERS: 29
Canada Vigilance: 1
Canada Vigilance
US FAERS
301Erectile dysfunctionFAERS: 29US FAERS
302Paranasal sinus discomfortFAERS: 29
Canada Vigilance: 1
Canada Vigilance
US FAERS
303PharyngitisFAERS: 29
Canada Vigilance: 1
Canada Vigilance
US FAERS
304SunburnFAERS: 29
Canada Vigilance: 2
Canada Vigilance
US FAERS
305Altered state of consciousnessFAERS: 28US FAERS
306Aspartate aminotransferase decreasedFAERS: 28US FAERS
307Blood creatinine increasedFAERS: 28
Canada Vigilance: 2
Canada Vigilance
US FAERS
308Cardiac ArrestFAERS: 28SIDER
US FAERS
309Oral candidiasisFAERS: 28
Canada Vigilance: 6
Canada Vigilance
US FAERS
310RestlessnessFAERS: 28
Canada Vigilance: 1
Canada Vigilance
US FAERS
311Tooth InfectionFAERS: 28US FAERS
312AgeusiaFAERS: 27US FAERS
313Bipolar DisorderFAERS: 27
Canada Vigilance: 6
Canada Vigilance
US FAERS
314Bowel movement irregularityFAERS: 27
Canada Vigilance: 1
Canada Vigilance
US FAERS
315Dental cariesFAERS: 27
Canada Vigilance: 4
Canada Vigilance
US FAERS
316DiverticulitisFAERS: 27US FAERS
317Gastrointestinal infectionFAERS: 27
Canada Vigilance: 2
Canada Vigilance
US FAERS
318HepatotoxicityFAERS: 27
Canada Vigilance: 4
Canada Vigilance
US FAERS
319Tension HeadacheFAERS: 27
Canada Vigilance: 4
Canada Vigilance
US FAERS
320jaundiceFAERS: 27
Canada Vigilance: 1
Canada Vigilance
US FAERS
321Bladder dysfunctionFAERS: 26
Canada Vigilance: 1
Canada Vigilance
US FAERS
322Completed SuicideFAERS: 26
Canada Vigilance: 3
Canada Vigilance
US FAERS
323Expired product administeredFAERS: 26US FAERS
324Exposure via partnerFAERS: 26US FAERS
325Facial ParesisFAERS: 26US FAERS
326JC virus infectionFAERS: 26US FAERS
327Motion SicknessFAERS: 26
Canada Vigilance: 1
Canada Vigilance
US FAERS
328Optic AtrophyFAERS: 26
Canada Vigilance: 3
Canada Vigilance
US FAERS
329Arthropod biteFAERS: 25
Canada Vigilance: 1
Canada Vigilance
US FAERS
330HerniaFAERS: 25
Canada Vigilance: 3
Canada Vigilance
US FAERS
331Lyme DiseaseFAERS: 25US FAERS
332Medication ErrorFAERS: 25US FAERS
333PericarditisFAERS: 25
Canada Vigilance: 2
Canada Vigilance
US FAERS
334Acute myocardial infarctionFAERS: 24
Canada Vigilance: 2
Canada Vigilance
US FAERS
335ColitisFAERS: 24US FAERS
336Deep Vein ThrombosisFAERS: 24
Canada Vigilance: 1
Canada Vigilance
US FAERS
337Pain of skinFAERS: 24
Canada Vigilance: 4
Canada Vigilance
US FAERS
338Sinus headacheFAERS: 24US FAERS
339Therapy cessationFAERS: 24
Canada Vigilance: 1
Canada Vigilance
US FAERS
340Urinary hesitationFAERS: 24
Canada Vigilance: 3
Canada Vigilance
US FAERS
341White matter lesionFAERS: 24US FAERS
342furuncleFAERS: 24
Canada Vigilance: 3
Canada Vigilance
US FAERS
343Eye inflammationFAERS: 23US FAERS
344Gastric ulcerFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
345Hypertensive crisisFAERS: 23US FAERS
346Muscle FatigueFAERS: 23
Canada Vigilance: 2
Canada Vigilance
US FAERS
347MyopiaFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
348OphthalmoplegiaFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
349Product use issueFAERS: 23US FAERS
350Respiratory FailureFAERS: 23US FAERS
351Vulvovaginal mycotic infectionFAERS: 23
Canada Vigilance: 6
Canada Vigilance
US FAERS
352Accidental exposure to product by childFAERS: 22
Canada Vigilance: 2
Canada Vigilance
US FAERS
353Bowen's DiseaseFAERS: 22
Canada Vigilance: 2
Canada Vigilance
US FAERS
354General physical condition abnormalFAERS: 22US FAERS
355HyperventilationFAERS: 22US FAERS
356QuadriparesisFAERS: 22US FAERS
357Renal painFAERS: 22US FAERS
358Vitreous DetachmentFAERS: 22
Canada Vigilance: 4
Canada Vigilance
US FAERS
359ApathyFAERS: 21
Canada Vigilance: 1
Canada Vigilance
US FAERS
360EructationFAERS: 21
Canada Vigilance: 1
Canada Vigilance
US FAERS
361HypertransaminasaemiaFAERS: 21US FAERS
362Ligament ruptureFAERS: 21
Canada Vigilance: 1
Canada Vigilance
US FAERS
363MonoparesisFAERS: 21
Canada Vigilance: 1
Canada Vigilance
US FAERS
364OsteoporosisFAERS: 21US FAERS
365Posterior reversible encephalopathy syndromeFAERS: 21
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
366PyelonephritisFAERS: 21
Canada Vigilance: 1
Canada Vigilance
US FAERS
367Rotator cuff syndromeFAERS: 21US FAERS
368Sinus TachycardiaFAERS: 21US FAERS
369Apparent deathFAERS: 20
Canada Vigilance: 2
Canada Vigilance
US FAERS
370Blood iron decreasedFAERS: 20
Canada Vigilance: 1
Canada Vigilance
US FAERS
371BradyphreniaFAERS: 20US FAERS
372Feeling of body temperature changeFAERS: 20
Canada Vigilance: 2
Canada Vigilance
US FAERS
373FractureFAERS: 20
Canada Vigilance: 1
Canada Vigilance
US FAERS
374HyperreflexiaFAERS: 20US FAERS
375LeukocytosisFAERS: 20US FAERS
376Malignant melanoma in situFAERS: 20US FAERS
377Mental status changesFAERS: 20
Canada Vigilance: 1
Canada Vigilance
US FAERS
378MetamorphopsiaFAERS: 20
Canada Vigilance: 1
Canada Vigilance
US FAERS
379QuadriplegiaFAERS: 20US FAERS
380Respiratory tract congestionFAERS: 20
Canada Vigilance: 1
Canada Vigilance
US FAERS
381Skin UlcerFAERS: 20US FAERS
382Blood sodium decreasedFAERS: 19US FAERS
383CholecystitisFAERS: 19US FAERS
384Depressed Level of ConsciousnessFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
385HepatomegalyFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
386Lip swellingFAERS: 19US FAERS
387Middle insomniaFAERS: 19
Canada Vigilance: 2
Canada Vigilance
US FAERS
388Psychiatric symptomFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
389RetchingFAERS: 19US FAERS
390Rheumatoid ArthritisFAERS: 19US FAERS
391Unresponsive to stimuliFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
392AbscessFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
393AneurysmFAERS: 18US FAERS
394Gastrointestinal PainFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
395Initial insomniaFAERS: 18
Canada Vigilance: 2
Canada Vigilance
US FAERS
396Intervertebral Disc DegenerationFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
397Mental FatigueFAERS: 18
Canada Vigilance: 2
Canada Vigilance
US FAERS
398NocturiaFAERS: 18US FAERS
399ParanoiaFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
400ScabFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
401StrabismusFAERS: 18
Canada Vigilance: 3
Canada Vigilance
US FAERS
402AphagiaFAERS: 17US FAERS
403Brain stem syndromeFAERS: 17US FAERS
404CD4/CD8 ratio decreasedFAERS: 17US FAERS
405Ejection Fraction DecreasedFAERS: 17US FAERS
406FrustrationFAERS: 17US FAERS
407IncoherentFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
408Molluscum ContagiosumFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
409Monocyte count decreasedFAERS: 17US FAERS
410Secretion dischargeFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
411Thermal burnFAERS: 17US FAERS
412Uterine CancerFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
413AuraFAERS: 16US FAERS
414Blood albumin decreasedFAERS: 16US FAERS
415Blood creatine phosphokinase increasedFAERS: 16US FAERS
416Blood sodium increasedFAERS: 16US FAERS
417BursitisFAERS: 16
Canada Vigilance: 3
Canada Vigilance
US FAERS
418Clostridium difficile infectionFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
419Escherichia urinary tract infectionFAERS: 16US FAERS
420Genital HerpesFAERS: 16
Canada Vigilance: 2
Canada Vigilance
US FAERS
421HordeolumFAERS: 16
Canada Vigilance: 2
Canada Vigilance
US FAERS
422HyperkeratosisFAERS: 16
Canada Vigilance: 3
Canada Vigilance
US FAERS
423Increased upper airway secretionFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
424MetrorrhagiaFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
425OnychomycosisFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
426PancytopeniaFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
427Renal cystFAERS: 16
Canada Vigilance: 2
Canada Vigilance
US FAERS
428Retinal cystFAERS: 16
Canada Vigilance: 2
Canada Vigilance
US FAERS
429Sensitivity to weather changeFAERS: 16US FAERS
430Upper-airway cough syndromeFAERS: 16
Canada Vigilance: 2
Canada Vigilance
US FAERS
431DyschromatopsiaFAERS: 15
Canada Vigilance: 4
Canada Vigilance
US FAERS
432Injection site painFAERS: 15US FAERS
433LymphomaFAERS: 15SIDER
US FAERS
434Pericardial effusionFAERS: 15
Canada Vigilance: 2
Canada Vigilance
US FAERS
435PolyuriaFAERS: 15US FAERS
436ScotomaFAERS: 15US FAERS
437Sexual DysfunctionFAERS: 15US FAERS
438Tinea PedisFAERS: 15US FAERS
439Anti-JC virus antibody indexFAERS: 14US FAERS
440Aphthous StomatitisFAERS: 14US FAERS
441Bilirubin conjugated increasedFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
442Blood potassium increasedFAERS: 14US FAERS
443EncephalitisFAERS: 14US FAERS
444Euphoric moodFAERS: 14
Canada Vigilance: 2
Canada Vigilance
US FAERS
445Human papilloma virus test positiveFAERS: 14US FAERS
446Nerve injuryFAERS: 14US FAERS
447Neutrophil percentage increasedFAERS: 14US FAERS
448Post procedural complicationFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
449Subcutaneous AbscessFAERS: 14US FAERS
450Supraventricular tachycardiaFAERS: 14US FAERS
451Thyroid NeoplasmFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
452Tongue bitingFAERS: 14US FAERS
453TonsillitisFAERS: 14
Canada Vigilance: 2
Canada Vigilance
US FAERS
454Tooth LossFAERS: 14US FAERS
455UlcerFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
456Aortic AneurysmFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
457Bladder discomfortFAERS: 13US FAERS
458Cerebral InfarctionFAERS: 13US FAERS
459Complex partial seizuresFAERS: 13US FAERS
460Depression suicidalFAERS: 13US FAERS
461Foreign body sensation in eyesFAERS: 13
Canada Vigilance: 3
Canada Vigilance
US FAERS
462Herpes dermatitisFAERS: 13US FAERS
463HypoxiaFAERS: 13US FAERS
464Intervertebral disc disorderFAERS: 13US FAERS
465Intestinal ObstructionFAERS: 13US FAERS
466Intracranial AneurysmFAERS: 13US FAERS
467LabyrinthitisFAERS: 13US FAERS
468Lipase increasedFAERS: 13US FAERS
469MastitisFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
470MeningiomaFAERS: 13US FAERS
471MeningitisFAERS: 13US FAERS
472Pancreatic carcinomaFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
473Panic DisorderFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
474ParaplegiaFAERS: 13US FAERS
475Prescribed overdoseFAERS: 13US FAERS
476Quality of life decreasedFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
477Retinal DegenerationFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
478RhinitisFAERS: 13US FAERS
479Therapy non-responderFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
480Urge IncontinenceFAERS: 13US FAERS
481Viral vasculitisFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
482Wrong technique in product usage processFAERS: 13US FAERS
483BronchospasmFAERS: 12US FAERS
484BruxismFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
485CD8 lymphocytes decreasedFAERS: 12US FAERS
486CholestasisFAERS: 12US FAERS
487Epigastric discomfortFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
488FolliculitisFAERS: 12US FAERS
489Food AllergyFAERS: 12US FAERS
490Gamma-glutamyltransferase decreasedFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
491Gastrointestinal carcinomaFAERS: 12US FAERS
492Live BirthFAERS: 12US FAERS
493Lymphomatoid PapulosisFAERS: 12
Canada Vigilance: 2
Canada Vigilance
US FAERS
494MaculeFAERS: 12US FAERS
495Mycosis FungoidesFAERS: 12US FAERS
496MydriasisFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
497NoduleFAERS: 12US FAERS
498Optic NeuropathyFAERS: 12US FAERS
499Otitis MediaFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
500Paternal exposure during pregnancyFAERS: 12US FAERS
501PresbyopiaFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
502Product physical issueFAERS: 12US FAERS
503Protein urine presentFAERS: 12US FAERS
504Skin reactionFAERS: 12US FAERS
505Slow speechFAERS: 12US FAERS
506Spinal column stenosisFAERS: 12US FAERS
507XerosisFAERS: 12US FAERS
508Anal squamous cell carcinomaFAERS: 11US FAERS
509BlepharitisFAERS: 11US FAERS
510Blood creatinine decreasedFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
511DiplegiaFAERS: 11US FAERS
512Drug effect incompleteFAERS: 11US FAERS
513Herpes zoster cutaneous disseminatedFAERS: 11US FAERS
514HyperthyroidismFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
515InfarctionFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
516Iron deficiencyFAERS: 11US FAERS
517Low birth weight babyFAERS: 11
Canada Vigilance: 2
Canada Vigilance
US FAERS
518Macular fibrosisFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
519Neuromyelitis OpticaFAERS: 11US FAERS
520ObesityFAERS: 11US FAERS
521Ocular icterusFAERS: 11
Canada Vigilance: 2
Canada Vigilance
US FAERS
522OsteomyelitisFAERS: 11US FAERS
523Pulmonary HypertensionFAERS: 11US FAERS
524Respiratory distressFAERS: 11US FAERS
525Sebaceous hyperplasiaFAERS: 11US FAERS
526SplenomegalyFAERS: 11US FAERS
527VasculitisFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
528Vulvovaginal pruritusFAERS: 11US FAERS
529YawningFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
530Altered visual depth perceptionFAERS: 10US FAERS
531AngioedemaFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
532AsphyxiaFAERS: 10US FAERS
533Atypical pneumoniaFAERS: 10US FAERS
534Blood magnesium decreasedFAERS: 10US FAERS
535Blood thyroid stimulating hormone increasedFAERS: 10US FAERS
536Concomitant disease progressionFAERS: 10US FAERS
537DroolingFAERS: 10US FAERS
538Drug exposure during pregnancyFAERS: 10US FAERS
539DyslexiaFAERS: 10US FAERS
540Epstein-Barr virus antibody positiveFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
541Exposure to toxic agentFAERS: 10US FAERS
542Full blood count abnormalFAERS: 10US FAERS
543Heat ExhaustionFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
544IridocyclitisFAERS: 10US FAERS
545Meniscus injuryFAERS: 10
Canada Vigilance: 2
Canada Vigilance
US FAERS
546OnychoclasisFAERS: 10US FAERS
547OverweightFAERS: 10US FAERS
548PetechiaeFAERS: 10US FAERS
549Rectal dischargeFAERS: 10US FAERS
550Sjogren's SyndromeFAERS: 10US FAERS
551Synovial CystFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
552Tongue discomfortFAERS: 10US FAERS
553Toxicity to various agentsFAERS: 10US FAERS
554TuberculosisFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
555Vestibular NeuronitisFAERS: 10US FAERS
556Abdominal AbscessFAERS: 9US FAERS
557Accidental exposure to productFAERS: 9US FAERS
558Acute sinusitisFAERS: 9US FAERS
559AmblyopiaFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
560AstigmatismFAERS: 9US FAERS
561Autoimmune hepatitisFAERS: 9US FAERS
562Blood albumin increasedFAERS: 9US FAERS
563Cervical polypFAERS: 9US FAERS
564Complication associated with deviceFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
565Dengue FeverFAERS: 9US FAERS
566Electrocardiogram QT interval abnormalFAERS: 9US FAERS
567GingivitisFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
568HydrocephalusFAERS: 9US FAERS
569HyperchlorhydriaFAERS: 9US FAERS
570Increased tendency to bruiseFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
571Injection Site ReactionFAERS: 9US FAERS
572Joint InstabilityFAERS: 9US FAERS
573Liver function test decreasedFAERS: 9US FAERS
574Nasal discomfortFAERS: 9US FAERS
575Neurological decompensationFAERS: 9US FAERS
576Noninfective encephalitisFAERS: 9US FAERS
577OsteopeniaFAERS: 9US FAERS
578Pelvic PainFAERS: 9
Canada Vigilance: 2
Canada Vigilance
US FAERS
579PhlebitisFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
580PleurisyFAERS: 9US FAERS
581PneumothoraxFAERS: 9US FAERS
582Pre-EclampsiaFAERS: 9US FAERS
583Precancerous skin lesionFAERS: 9US FAERS
584PregnancyFAERS: 9US FAERS
585Retinal exudatesFAERS: 9
Canada Vigilance: 3
Canada Vigilance
US FAERS
586Retinal thickeningFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
587ScreamingFAERS: 9US FAERS
588Septic ShockFAERS: 9US FAERS
589Spinal column injuryFAERS: 9US FAERS
590TrismusFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
591Unevaluable eventFAERS: 9US FAERS
592Varicella Zoster Virus InfectionFAERS: 9
Canada Vigilance: 4
Canada Vigilance
US FAERS
593Abdominal InfectionFAERS: 8US FAERS
594Abdominal tendernessFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
595Alanine aminotransferase abnormalFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
596Atrial FlutterFAERS: 8US FAERS
597Bacterial VaginosisFAERS: 8US FAERS
598Biliary ColicFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
599Blood immunoglobulin G decreasedFAERS: 8US FAERS
600Blood iron increasedFAERS: 8US FAERS
601Blood phosphorus decreasedFAERS: 8US FAERS
602Blood uric acid decreasedFAERS: 8US FAERS
603Breast CystFAERS: 8US FAERS
604Breast cancer stage IIIFAERS: 8US FAERS
605Colon adenomaFAERS: 8US FAERS
606Decreased vibratory senseFAERS: 8
Canada Vigilance: 2
Canada Vigilance
US FAERS
607Detachment of retinal pigment epitheliumFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
608Drug prescribing errorFAERS: 8US FAERS
609DystoniaFAERS: 8US FAERS
610Electrocardiogram repolarisation abnormalityFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
611EndometriosisFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
612Escherichia infectionFAERS: 8
Canada Vigilance: 2
Canada Vigilance
US FAERS
613Essential HypertensionFAERS: 8US FAERS
614Gaze palsyFAERS: 8US FAERS
615GlossitisFAERS: 8US FAERS
616Hepatic enzyme decreasedFAERS: 8US FAERS
617Impaired work abilityFAERS: 8US FAERS
618Injection site erythemaFAERS: 8US FAERS
619Intestinal PerforationFAERS: 8US FAERS
620Intraocular pressure test abnormalFAERS: 8US FAERS
621Latent TuberculosisFAERS: 8US FAERS
622Loss of personal independence in daily activitiesFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
623LymphadenitisFAERS: 8US FAERS
624Mouth swellingFAERS: 8US FAERS
625Negative thoughtsFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
626PeritonitisFAERS: 8US FAERS
627PoisoningFAERS: 8US FAERS
628PolyneuropathyFAERS: 8US FAERS
629QRS axis abnormalFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
630Renal Cell CarcinomaFAERS: 8US FAERS
631SarcomaFAERS: 8US FAERS
632Skin lacerationFAERS: 8
Canada Vigilance: 2
Canada Vigilance
US FAERS
633TracheitisFAERS: 8US FAERS
634Transferrin decreasedFAERS: 8US FAERS
635Urine flow decreasedFAERS: 8US FAERS
636Uterine PolypFAERS: 8US FAERS
637prostatitisFAERS: 8US FAERS
638skin abrasionFAERS: 8US FAERS
639Acute kidney injuryFAERS: 7US FAERS
640Adverse eventFAERS: 7US FAERS
641Amylase decreasedFAERS: 7US FAERS
642AnhedoniaFAERS: 7US FAERS
643Animal biteFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
644Ankylosing spondylitisFAERS: 7US FAERS
645ArteriosclerosisFAERS: 7US FAERS
646Arthropod stingFAERS: 7US FAERS
647AscitesFAERS: 7US FAERS
648B-lymphocyte count decreasedFAERS: 7US FAERS
649Benign neoplasm of skinFAERS: 7US FAERS
650Birth markFAERS: 7US FAERS
651Bone lesionFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
652Breech PresentationFAERS: 7US FAERS
653CardiomegalyFAERS: 7US FAERS
654Cell DeathFAERS: 7US FAERS
655Cluster HeadacheFAERS: 7US FAERS
656Deja VuFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
657Drug withdrawal syndromeFAERS: 7US FAERS
658Endometrial adenocarcinomaFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
659Extraocular Muscle ParesisFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
660FormicationFAERS: 7US FAERS
661GlioblastomaFAERS: 7US FAERS
662Haptoglobin increasedFAERS: 7US FAERS
663Hormone level abnormalFAERS: 7US FAERS
664ImpatienceFAERS: 7US FAERS
665Inappropriate affectFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
666Incorrect product storageFAERS: 7US FAERS
667Infectious MononucleosisFAERS: 7US FAERS
668IritisFAERS: 7US FAERS
669MyelitisFAERS: 7
Canada Vigilance: 4
Canada Vigilance
US FAERS
670MyoclonusFAERS: 7US FAERS
671MyositisFAERS: 7US FAERS
672NarcolepsyFAERS: 7US FAERS
673Nasal inflammationFAERS: 7US FAERS
674Oropharyngeal blisteringFAERS: 7US FAERS
675OsteitisFAERS: 7US FAERS
676Pancreatic enzymes increasedFAERS: 7US FAERS
677PleocytosisFAERS: 7US FAERS
678PneumonitisFAERS: 7US FAERS
679Post-Traumatic Stress DisorderFAERS: 7US FAERS
680Precancerous cells presentFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
681Product storage errorFAERS: 7US FAERS
682Renal massFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
683Retinal VasculitisFAERS: 7US FAERS
684Retinal Vein OcclusionFAERS: 7US FAERS
685Skin neoplasm excisionFAERS: 7US FAERS
686Therapy changeFAERS: 7US FAERS
687TrichorrhexisFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
688Anaphylactic shockFAERS: 6US FAERS
689AnosmiaFAERS: 6US FAERS
690BedriddenFAERS: 6US FAERS
691Benign NeoplasmFAERS: 6US FAERS
692Bladder painFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
693Blood lactate dehydrogenase increasedFAERS: 6US FAERS
694Cardiac enzymes increasedFAERS: 6US FAERS
695Compression fractureFAERS: 6US FAERS
696DeliriumFAERS: 6US FAERS
697Device related infectionFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
698Diabetic RetinopathyFAERS: 6US FAERS
699Diffuse Large B-Cell LymphomaFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
700Ectopic PregnancyFAERS: 6US FAERS
701Electrocardiogram ST segment abnormalFAERS: 6US FAERS
702Erythema NodosumFAERS: 6US FAERS
703ExophthalmosFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
704Exposure during breast feedingFAERS: 6US FAERS
705Eye allergyFAERS: 6US FAERS
706Gastrointestinal inflammationFAERS: 6US FAERS
707Gastrointestinal sounds abnormalFAERS: 6US FAERS
708Genital rashFAERS: 6US FAERS
709GoutFAERS: 6US FAERS
710Head titubationFAERS: 6US FAERS
711Hepatic InfectionFAERS: 6US FAERS
712Herpes Zoster OticusFAERS: 6US FAERS
713Infrequent bowel movementsFAERS: 6US FAERS
714Intentional product misuseFAERS: 6US FAERS
715Intracranial massFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
716Intraspinal abscessFAERS: 6US FAERS
717Keratosis pilarisFAERS: 6US FAERS
718Lactose IntoleranceFAERS: 6US FAERS
719Left Ventricular HypertrophyFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
720LipomaFAERS: 6US FAERS
721Lumbar radiculopathyFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
722LymphocytosisFAERS: 6US FAERS
723Macular pigmentationFAERS: 6US FAERS
724MalnutritionFAERS: 6US FAERS
725Monocyte percentage increasedFAERS: 6US FAERS
726Ocular HypertensionFAERS: 6US FAERS
727Oropharyngeal discomfortFAERS: 6US FAERS
728Performance status decreasedFAERS: 6US FAERS
729PolydipsiaFAERS: 6US FAERS
730Post procedural infectionFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
731Post-traumatic neck syndromeFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
732Protein total decreasedFAERS: 6US FAERS
733PterygiumFAERS: 6US FAERS
734RadiculopathyFAERS: 6US FAERS
735ScleritisFAERS: 6US FAERS
736Sinus painFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
737Skin irritationFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
738Tendon sheath disorderFAERS: 6US FAERS
739Trigeminal Nerve DisorderFAERS: 6US FAERS
740Upper respiratory tract congestionFAERS: 6US FAERS
741Vaginal DischargeFAERS: 6US FAERS
742Vertebral Artery DissectionFAERS: 6US FAERS
743Visual acuity tests abnormalFAERS: 6US FAERS
744Vulvovaginal burning sensationFAERS: 6US FAERS
745Wheelchair userFAERS: 6US FAERS
746Wrong technique in drug usage processFAERS: 6US FAERS
747leiomyosarcomaFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
748muscle injuryFAERS: 6US FAERS
749Abdominal massFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
750Acute respiratory failureFAERS: 5US FAERS
751AdenocarcinomaFAERS: 5US FAERS
752Adjustment disorder with depressed moodFAERS: 5US FAERS
753Alcohol IntoleranceFAERS: 5US FAERS
754Anti-thyroid antibody positiveFAERS: 5US FAERS
755Blood brain barrier defectFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
756Blood glucose abnormalFAERS: 5US FAERS
757Blood immunoglobulin G increasedFAERS: 5US FAERS
758Brain AbscessFAERS: 5US FAERS
759Brain natriuretic peptide increasedFAERS: 5US FAERS
760Breast discomfortFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
761Burning Mouth SyndromeFAERS: 5US FAERS
762CD4 lymphocyte percentage decreasedFAERS: 5US FAERS
763CD8 lymphocyte percentage increasedFAERS: 5US FAERS
764CachexiaFAERS: 5US FAERS
765Carcinoma in SituFAERS: 5US FAERS
766Cardiac discomfortFAERS: 5US FAERS
767Cerebellar AtaxiaFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
768Choking sensationFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
769Cholecystitis infectiveFAERS: 5US FAERS
770ChoroiditisFAERS: 5US FAERS
771Chronic sinusitisFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
772ClaustrophobiaFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
773Congenital hydronephrosisFAERS: 5US FAERS
774Diabetes InsipidusFAERS: 5US FAERS
775DrowningFAERS: 5US FAERS
776Drug dispensing errorFAERS: 5US FAERS
777Endometrial HyperplasiaFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
778EnuresisFAERS: 5US FAERS
779Erythema MultiformeFAERS: 5US FAERS
780ExcoriationFAERS: 5US FAERS
781Expired drug administeredFAERS: 5US FAERS
782Extranodal marginal zone B-cell lymphoma (MALT type)FAERS: 5US FAERS
783Eyelid margin crustingFAERS: 5US FAERS
784Food cravingFAERS: 5US FAERS
785HemiparaesthesiaFAERS: 5US FAERS
786Hepatitis B surface antibody positiveFAERS: 5US FAERS
787HydronephrosisFAERS: 5US FAERS
788HyperpyrexiaFAERS: 5US FAERS
789HypophagiaFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
790Impaired driving abilityFAERS: 5US FAERS
791Intention tremorFAERS: 5US FAERS
792Intentional self-injuryFAERS: 5US FAERS
793KeratitisFAERS: 5US FAERS
794Left atrial dilatationFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
795LymphangitisFAERS: 5US FAERS
796MacrocytosisFAERS: 5US FAERS
797Mechanical urticariaFAERS: 5US FAERS
798MenopauseFAERS: 5US FAERS
799Mononucleosis syndromeFAERS: 5US FAERS
800Mucosal InfectionFAERS: 5US FAERS
801Nail InfectionFAERS: 5US FAERS
802NeuritisFAERS: 5US FAERS
803Obsessive-Compulsive DisorderFAERS: 5US FAERS
804Oculogyric crisisFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
805Oral infectionFAERS: 5US FAERS
806PeriarthritisFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
807Poor peripheral circulationFAERS: 5US FAERS
808Posterior capsule opacificationFAERS: 5US FAERS
809Product packaging issueFAERS: 5US FAERS
810Product prescribing errorFAERS: 5US FAERS
811Product quality issueFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
812Protein total increasedFAERS: 5US FAERS
813Pulmonary function test decreasedFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
814Renal ColicFAERS: 5US FAERS
815Respiratory tract infection viralFAERS: 5US FAERS
816Scarlet FeverFAERS: 5US FAERS
817Sensorimotor disorderFAERS: 5US FAERS
818SnoringFAERS: 5US FAERS
819Stress at workFAERS: 5US FAERS
820TachyarrhythmiaFAERS: 5US FAERS
821TalipesFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
822Teeth brittleFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
823Thyroid hormones decreasedFAERS: 5US FAERS
824Tongue blisteringFAERS: 5US FAERS
825Troponin increasedFAERS: 5US FAERS
826UnderweightFAERS: 5US FAERS
827Wolff-Parkinson-White SyndromeFAERS: 5US FAERS
828Abdominal adhesionsFAERS: 4US FAERS
829Anal abscessFAERS: 4US FAERS
830Anaphylactoid ReactionFAERS: 4US FAERS
831Anaplastic large cell lymphoma T- and null-cell typesFAERS: 4US FAERS
832Angle Closure GlaucomaFAERS: 4US FAERS
833Autoimmune uveitisFAERS: 4US FAERS
834Avulsion fractureFAERS: 4US FAERS
835Biliary dilatationFAERS: 4US FAERS
836Bladder prolapseFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
837Blighted ovumFAERS: 4US FAERS
838Blood cholesterol abnormalFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
839Blood glucose fluctuationFAERS: 4US FAERS
840Blood thyroid stimulating hormone decreasedFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
841Bone decalcificationFAERS: 4US FAERS
842Breast cancer recurrentFAERS: 4US FAERS
843Breast cancer stage IIFAERS: 4US FAERS
844Breast tendernessFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
845BronchiolitisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
846Central Nervous System InfectionFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
847Cerebrovascular InsufficiencyFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
848CholangitisFAERS: 4US FAERS
849ChromatopsiaFAERS: 4US FAERS
850ClonusFAERS: 4US FAERS
851Clostridium difficile colitisFAERS: 4US FAERS
852Computer vision syndromeFAERS: 4US FAERS
853Coronary Artery DiseaseFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
854Cryptococcal cutaneous infectionFAERS: 4US FAERS
855CyanosisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
856DermatophytosisFAERS: 4US FAERS
857Diabetic KetoacidosisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
858Drug DependenceFAERS: 4US FAERS
859Dry age-related macular degenerationFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
860DysenteryFAERS: 4US FAERS
861EcchymosisFAERS: 4US FAERS
862Electrocardiogram ST-T segment abnormalFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
863Electrocardiogram T wave peakedFAERS: 4US FAERS
864Electrocardiogram changeFAERS: 4US FAERS
865Enzyme level increasedFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
866EpicondylitisFAERS: 4US FAERS
867ErysipelasFAERS: 4US FAERS
868Escherichia sepsisFAERS: 4US FAERS
869Extremity contractureFAERS: 4US FAERS
870Eye BurnsFAERS: 4US FAERS
871Gamma-glutamyltransferase abnormalFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
872Gastric infectionFAERS: 4US FAERS
873Granulocyte count increasedFAERS: 4US FAERS
874GranulomaFAERS: 4US FAERS
875Guillain-Barre SyndromeFAERS: 4US FAERS
876Heat illnessFAERS: 4US FAERS
877Hepatitis AFAERS: 4US FAERS
878Human EhrlichiosisFAERS: 4US FAERS
879HyperacusisFAERS: 4US FAERS
880IleusFAERS: 4US FAERS
881Immune reconstitution syndromeFAERS: 4US FAERS
882Immunoglobulins abnormalFAERS: 4US FAERS
883Immunology test abnormalFAERS: 4US FAERS
884Impaired gastric emptyingFAERS: 4US FAERS
885ImpetigoFAERS: 4US FAERS
886Influenza A virus test positiveFAERS: 4US FAERS
887IntertrigoFAERS: 4US FAERS
888Lentigo maligna stage unspecifiedFAERS: 4US FAERS
889Limb massFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
890Mastication disorderFAERS: 4US FAERS
891MetaplasiaFAERS: 4US FAERS
892MetatarsalgiaFAERS: 4US FAERS
893Multiple MyelomaFAERS: 4US FAERS
894Myasthenia GravisFAERS: 4US FAERS
895Mycobacterium tuberculosis complex test positiveFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
896NeurodermatitisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
897NeuromaFAERS: 4US FAERS
898Nonspecific reactionFAERS: 4US FAERS
899Ophthalmological examination abnormalFAERS: 4US FAERS
900Oral fungal infectionFAERS: 4US FAERS
901ParakeratosisFAERS: 4US FAERS
902PertussisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
903PhonophobiaFAERS: 4US FAERS
904Product blister packaging issueFAERS: 4US FAERS
905Pulmonary FibrosisFAERS: 424893116CTD
US FAERS
906Pulmonary thrombosisFAERS: 4US FAERS
907PurpuraFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
908RegurgitationFAERS: 4US FAERS
909Retinal DrusenFAERS: 4US FAERS
910Retinal migraineFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
911Retinal telangiectasiaFAERS: 4US FAERS
912RetinitisFAERS: 4US FAERS
913Romberg test positiveFAERS: 4US FAERS
914SclerodermaFAERS: 4US FAERS
915Seizure like phenomenaFAERS: 4US FAERS
916Serotonin SyndromeFAERS: 4US FAERS
917Sick Sinus SyndromeFAERS: 4US FAERS
918Sinusitis aspergillusFAERS: 4US FAERS
919Slow response to stimuliFAERS: 4US FAERS
920Sphincter of Oddi DysfunctionFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
921StuporFAERS: 4US FAERS
922Superficial injury of eyeFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
923TachyphreniaFAERS: 4US FAERS
924TenosynovitisFAERS: 4US FAERS
925TensionFAERS: 4US FAERS
926Therapeutic product effect incompleteFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
927ThrombocytosisFAERS: 4US FAERS
928Tonic clonic movementsFAERS: 4US FAERS
929Varicella virus test positiveFAERS: 4US FAERS
930VasospasmFAERS: 4US FAERS
931Ventricular arrhythmiaFAERS: 4US FAERS
932Vitreous adhesionsFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
933Vulvovaginal painFAERS: 4US FAERS
934Walking distance test abnormalFAERS: 4US FAERS
935Wound InfectionFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
936Wrong drug administeredFAERS: 4US FAERS
937fibromaFAERS: 4US FAERS
938liposarcomaFAERS: 4US FAERS
939Abdominal rigidityFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
940AcarodermatitisFAERS: 3US FAERS
941Acinetobacter test positiveFAERS: 3US FAERS
942Albumin globulin ratio increasedFAERS: 3US FAERS
943Alcohol Use DisorderFAERS: 3US FAERS
944Allergic reaction to excipientFAERS: 3US FAERS
945Amino acid level increasedFAERS: 3US FAERS
946Amylase increasedFAERS: 3US FAERS
947Anaplastic astrocytomaFAERS: 3US FAERS
948Anembryonic gestationFAERS: 3US FAERS
949Angular cheilitisFAERS: 3US FAERS
950AnuriaFAERS: 3US FAERS
951Atrial tachycardiaFAERS: 3US FAERS
952AversionFAERS: 3US FAERS
953Bacterial abdominal infectionFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
954BacteriuriaFAERS: 3US FAERS
955Bladder NeoplasmFAERS: 3US FAERS
956Bladder spasmFAERS: 3US FAERS
957Blood chloride increasedFAERS: 3US FAERS
958Blood creatine increasedFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
959Blood fibrinogen increasedFAERS: 3US FAERS
960Blood magnesium increasedFAERS: 3US FAERS
961Borderline glaucomaFAERS: 3US FAERS
962Butterfly rashFAERS: 3US FAERS
963CalcinosisFAERS: 3US FAERS
964Cancer PainFAERS: 3US FAERS
965Carbon dioxide increasedFAERS: 3US FAERS
966Carcinoembryonic antigen increasedFAERS: 3US FAERS
967Carotid artery occlusionFAERS: 3US FAERS
968Catheter site infectionFAERS: 3US FAERS
969Cerebral ThrombosisFAERS: 3US FAERS
970Chronic gastritisFAERS: 3US FAERS
971Complication of deliveryFAERS: 3US FAERS
972Corneal lesionFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
973Coronary artery insufficiencyFAERS: 3US FAERS
974Culture urine positiveFAERS: 3US FAERS
975CystoceleFAERS: 3US FAERS
976DependenceFAERS: 3US FAERS
977Dermatitis acneiformFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
978Diastolic dysfunctionFAERS: 3US FAERS
979Disturbance in sexual arousalFAERS: 3US FAERS
980DyscalculiaFAERS: 3US FAERS
981DyslaliaFAERS: 3US FAERS
982DysplasiaFAERS: 3US FAERS
983Ear congestionFAERS: 3US FAERS
984Echocardiogram abnormalFAERS: 3US FAERS
985Economic problemFAERS: 3US FAERS
986Elevated moodFAERS: 3US FAERS
987Enterococcal infectionFAERS: 3US FAERS
988EnterocolitisFAERS: 3US FAERS
989Eosinophil percentage increasedFAERS: 3US FAERS
990EosinophiliaFAERS: 3US FAERS
991EpididymitisFAERS: 3US FAERS
992Epileptic auraFAERS: 3US FAERS
993ErythromelalgiaFAERS: 3US FAERS
994EuthanasiaFAERS: 3US FAERS
995Eyelid irritationFAERS: 3US FAERS
996Eyelids pruritusFAERS: 3US FAERS
997Factor V Leiden mutationFAERS: 3US FAERS
998Fascial ruptureFAERS: 3US FAERS
999Fibroadenoma of breastFAERS: 3US FAERS
1000Foaming at mouthFAERS: 3US FAERS
1001Gallbladder painFAERS: 3US FAERS
1002GangreneFAERS: 3US FAERS
1003Gastrointestinal motility disorderFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
1004General physical condition decreasedFAERS: 3US FAERS
1005Gingival RecessionFAERS: 3US FAERS
1006Heat StrokeFAERS: 3US FAERS
1007Hepatitis CFAERS: 3US FAERS
1008Herpes zoster infection neurologicalFAERS: 3US FAERS
1009HistoplasmosisFAERS: 3US FAERS
1010HyperparathyroidismFAERS: 3US FAERS
1011Hypertensive heart diseaseFAERS: 3US FAERS
1012Hypertrophic CardiomyopathyFAERS: 3US FAERS
1013ImmobileFAERS: 3US FAERS
1014Incarcerated herniaFAERS: 3US FAERS
1015Incorrect drug administration durationFAERS: 3US FAERS
1016Incorrect route of drug administrationFAERS: 3US FAERS
1017Increased viscosity of bronchial secretionFAERS: 3US FAERS
1018Infectious peritonitisFAERS: 3US FAERS
1019Inflammatory marker increasedFAERS: 3US FAERS
1020Invasive Lobular Breast CarcinomaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
1021Irregular sleep phaseFAERS: 3US FAERS
1022Labile blood pressureFAERS: 3US FAERS
1023Lacrimation decreasedFAERS: 3US FAERS
1024Large intestine perforationFAERS: 3US FAERS
1025Lichen PlanusFAERS: 3US FAERS
1026Limb asymmetryFAERS: 3US FAERS
1027Lymphocytic infiltrationFAERS: 3US FAERS
1028MalariaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
1029Malignant melanoma stage IFAERS: 3US FAERS
1030Melanoma recurrentFAERS: 3US FAERS
1031Metabolic acidosisFAERS: 3US FAERS
1032Metabolic function test abnormalFAERS: 3US FAERS
1033Metastases to adrenalsFAERS: 3US FAERS
1034MetastasisFAERS: 3US FAERS
1035Microvascular coronary artery diseaseFAERS: 3US FAERS
1036Mixed liver injuryFAERS: 3US FAERS
1037MonocytosisFAERS: 3US FAERS
1038MyocarditisFAERS: 3US FAERS
1039Nasal herpesFAERS: 3US FAERS
1040Noninfective retinitisFAERS: 3US FAERS
1041PO2 decreasedFAERS: 3US FAERS
1042PanophthalmitisFAERS: 3US FAERS
1043PapillomaFAERS: 3US FAERS
1044Paranasal sinus hypersecretionFAERS: 3US FAERS
1045PiloerectionFAERS: 3US FAERS
1046Pityriasis RoseaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
1047Post procedural cellulitisFAERS: 3US FAERS
1048Postoperative wound complicationFAERS: 3US FAERS
1049Procedural complicationFAERS: 3US FAERS
1050Product availability issueFAERS: 3US FAERS
1051Product packaging quantity issueFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
1052Product taste abnormalFAERS: 3US FAERS
1053Pyloric StenosisFAERS: 3US FAERS
1054Radial nerve palsyFAERS: 3US FAERS
1055Radicular painFAERS: 3US FAERS
1056Reduced bladder capacityFAERS: 3US FAERS
1057Restrictive pulmonary diseaseFAERS: 3US FAERS
1058Retinal Vascular DisorderFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
1059Ruptured cerebral aneurysmFAERS: 3US FAERS
1060Sensory level abnormalFAERS: 3US FAERS
1061Sinoatrial BlockFAERS: 3US FAERS
1062Sinus rhythmFAERS: 3US FAERS
1063Skin tightnessFAERS: 3US FAERS
1064Solar dermatitisFAERS: 3US FAERS
1065Splenic RuptureFAERS: 3US FAERS
1066Stevens-Johnson SyndromeFAERS: 3US FAERS
1067StillbirthFAERS: 3US FAERS
1068Suture related complicationFAERS: 3US FAERS
1069Testicular embryonal carcinomaFAERS: 3US FAERS
1070Therapy partial responderFAERS: 3US FAERS
1071Thrombocytopenic purpuraFAERS: 3US FAERS
1072TracheobronchitisFAERS: 3US FAERS
1073Trisomy 21FAERS: 3US FAERS
1074Tympanic Membrane PerforationFAERS: 3US FAERS
1075Upper airway obstructionFAERS: 3US FAERS
1076Vascular ruptureFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
1077Venous stenosisFAERS: 3US FAERS
1078Ventricular DysfunctionFAERS: 3US FAERS
1079Ventricular FibrillationFAERS: 3US FAERS
1080Ventricular hypoplasiaFAERS: 3US FAERS
1081Viral test positiveFAERS: 3US FAERS
1082Visceral PainFAERS: 3US FAERS
1083Visual brightnessFAERS: 3US FAERS
1084VitritisFAERS: 3US FAERS
1085Vulvovaginal discomfortFAERS: 3US FAERS
1086West Nile viral infectionFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
1087Abnormal weight gainFAERS: 2US FAERS
1088AcanthomaFAERS: 2US FAERS
1089AcanthosisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
1090Accidental exposureFAERS: 2US FAERS
1091Acoustic NeuromaFAERS: 2US FAERS
1092Activities of daily living impairedFAERS: 2US FAERS
1093Acute Coronary SyndromeFAERS: 2US FAERS
1094Acute psychosisFAERS: 2US FAERS
1095Adnexa uteri massFAERS: 2US FAERS
1096Adrenal massFAERS: 2US FAERS
1097AgnosiaFAERS: 2US FAERS
1098AgraphiaFAERS: 2US FAERS
1099Allergy to arthropod stingFAERS: 2US FAERS
1100AllodyniaFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
1101Alopecia AreataFAERS: 2US FAERS
1102Amaurosis FugaxFAERS: 2US FAERS
1103Amyotrophic Lateral SclerosisFAERS: 2US FAERS
1104Anaplastic OligodendrogliomaFAERS: 2US FAERS
1105Animal scratchFAERS: 2US FAERS
1106Anti-aquaporin-4 antibody positiveFAERS: 2US FAERS
1107Antibody test negativeFAERS: 2US FAERS
1108Arterial thrombosisFAERS: 2US FAERS
1109Aspartate aminotransferase abnormalFAERS: 2US FAERS
1110AtelectasisFAERS: 2US FAERS
1111Autonomic nervous system imbalanceFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
1112Axonal neuropathyFAERS: 2US FAERS
1113BabesiosisFAERS: 2US FAERS
1114Bacterial disease carrierFAERS: 2US FAERS
1115Bacterial sepsisFAERS: 2US FAERS
1116Bacterial test positiveFAERS: 2US FAERS
1117Base excess decreasedFAERS: 2US FAERS
1118BelligerenceFAERS: 2US FAERS
1119Benign Prostatic HyperplasiaFAERS: 2US FAERS
1120Benign bone neoplasmFAERS: 2US FAERS
1121Benign neoplasm of thyroid glandFAERS: 2US FAERS
1122BicytopeniaFAERS: 2US FAERS
1123Blood blisterFAERS: 2US FAERS
1124Blood creatine decreasedFAERS: 2US FAERS
1125Blood creatinine abnormalFAERS: 2US FAERS
1126Blood glucagon increasedFAERS: 2US FAERS
1127Blood iron abnormalFAERS: 2US FAERS
1128Blood pH decreasedFAERS: 2US FAERS
1129Blood pressure inadequately controlledFAERS: 2US FAERS
1130Blood testosterone increasedFAERS: 2US FAERS
1131Blood triglycerides decreasedFAERS: 2US FAERS
1132Blood urea nitrogen/creatinine ratio increasedFAERS: 2US FAERS
1133Blood viscosity decreasedFAERS: 2US FAERS
1134Brain DeathFAERS: 2US FAERS
1135Bulbar palsyFAERS: 2US FAERS
1136C-reactive protein abnormalFAERS: 2US FAERS
1137Campylobacter infectionFAERS: 2US FAERS
1138Cardiac dysfunctionFAERS: 2US FAERS
1139Cardiac monitoring abnormalFAERS: 2US FAERS
1140Cardiac stress test abnormalFAERS: 2US FAERS
1141CardiotoxicityFAERS: 2US FAERS
1142Cardiovascular insufficiencyFAERS: 2US FAERS
1143CarditisFAERS: 2US FAERS
1144CataplexyFAERS: 2US FAERS
1145Cervix carcinoma stage IVFAERS: 2US FAERS
1146CheilitisFAERS: 2US FAERS
1147Chest wall cystFAERS: 2US FAERS
1148ChloasmaFAERS: 2US FAERS
1149CholangiolitisFAERS: 2US FAERS
1150ChorioretinitisFAERS: 2US FAERS
1151Complement factor C4 decreasedFAERS: 2US FAERS
1152Complement factor decreasedFAERS: 2US FAERS
1153Congenital choroid plexus cystFAERS: 2US FAERS
1154Congenital inguinal herniaFAERS: 2US FAERS
1155Congenital torticollisFAERS: 2US FAERS
1156Corneal ScarFAERS: 2US FAERS
1157Corneal thickeningFAERS: 2US FAERS
1158Cubital Tunnel SyndromeFAERS: 2US FAERS
1159Cytomegalovirus test positiveFAERS: 2US FAERS
1160Dacryostenosis acquiredFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
1161DeformityFAERS: 2US FAERS
1162Dental discomfortFAERS: 2US FAERS
1163Deposit eyeFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
1164Detachment of macular retinal pigment epitheliumFAERS: 2US FAERS
1165Developmental Coordination DisorderFAERS: 2US FAERS
1166Diabetes mellitus inadequate controlFAERS: 2US FAERS
1167Diastolic hypertensionFAERS: 2US FAERS
1168Disability assessment scale score increasedFAERS: 2US FAERS
1169DissociationFAERS: 2US FAERS
1170DiverticulumFAERS: 2US FAERS
1171Dreamy stateFAERS: 2US FAERS
1172Drug ToleranceFAERS: 2US FAERS
1173Drug effect delayedFAERS: 2US FAERS
1174Drug level increasedFAERS: 2US FAERS
1175Drug resistanceFAERS: 2US FAERS
1176DuodenitisFAERS: 2US FAERS
1177Electrocardiogram RR interval prolongedFAERS: 2US FAERS
1178Electrocardiogram ST-T changeFAERS: 2US FAERS
1179Electrolyte imbalanceFAERS: 2US FAERS
1180Epstein-Barr virus associated lymphoproliferative disorderFAERS: 2US FAERS
1181Exaggerated startle responseFAERS: 2US FAERS
1182Excessive cerumen productionFAERS: 2US FAERS
1183Exposure to radiationFAERS: 2US FAERS
1184Eye symptomFAERS: 2US FAERS
1185Eyelid painFAERS: 2US FAERS
1186Facial NeuralgiaFAERS: 2US FAERS
1187Fallopian tube obstructionFAERS: 2US FAERS
1188False positive investigation resultFAERS: 2US FAERS
1189Fear of fallingFAERS: 2US FAERS
1190Feelings of worthlessnessFAERS: 2US FAERS
1191Fibrin D dimer increasedFAERS: 2US FAERS
1192FibrosisFAERS: 2US FAERS
1193Fluid overloadFAERS: 2US FAERS
1194Focal dyscognitive seizuresFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
1195FumblingFAERS: 2US FAERS
1196Fungal test positiveFAERS: 2US FAERS
1197Gastric pH decreasedFAERS: 2US FAERS
1198Gastrointestinal ulcerFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
1199Gastrointestinal viral infectionFAERS: 2US FAERS
1200Gene MutationFAERS: 2US FAERS
1201General symptomFAERS: 2US FAERS
1202Gestational DiabetesFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
1203GliomaFAERS: 2US FAERS
1204GliosisFAERS: 2US FAERS
1205Haptoglobin DecreasedFAERS: 2US FAERS
1206Heavy exposure to ultraviolet lightFAERS: 2US FAERS
1207Hepatitis B virus test positiveFAERS: 2US FAERS
1208Hepatitis BFAERS: 2US FAERS
1209Hepatitis C antibody positiveFAERS: 2US FAERS
1210HidradenitisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
1211Human polyomavirus infectionFAERS: 2US FAERS
1212HyperphagiaFAERS: 2US FAERS
1213HyperplasiaFAERS: 2US FAERS
1214Hyperplastic cholecystopathyFAERS: 2US FAERS
1215HypomaniaFAERS: 2US FAERS
1216HyporeflexiaFAERS: 2US FAERS
1217HypospadiasFAERS: 2US FAERS
1218Idiopathic guttate hypomelanosisFAERS: 2US FAERS
1219IleitisFAERS: 2US FAERS
1220Immunodeficiency congenitalFAERS: 2US FAERS
1221Implant site infectionFAERS: 2US FAERS
1222IndurationFAERS: 2US FAERS
1223Infected cystFAERS: 2US FAERS
1224InfertilityFAERS: 2US FAERS
1225Influenza virus test positiveFAERS: 2US FAERS
1226Injection site pruritusFAERS: 2US FAERS
1227Intentional product use issueFAERS: 2US FAERS
1228Intestinal adenocarcinomaFAERS: 2US FAERS
1229Intestinal cystFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
1230Intracranial HypotensionFAERS: 2US FAERS
1231Intraductal papilloma of breastFAERS: 2US FAERS
1232Intraocular pressure testFAERS: 2US FAERS
1233Jamais vuFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
1234Joint Range of Motion DecreasedFAERS: 2US FAERS
1235Lack of spontaneous speechFAERS: 2US FAERS
1236LagophthalmosFAERS: 2US FAERS
1237Laryngeal Squamous Cell CarcinomaFAERS: 2US FAERS
1238LaryngospasmFAERS: 2US FAERS
1239LazinessFAERS: 2US FAERS
1240Limb crushing injuryFAERS: 2US FAERS
1241Livedo ReticularisFAERS: 2US FAERS
1242Locked-In SyndromeFAERS: 2US FAERS
1243Long QT SyndromeFAERS: 225223691CTD
US FAERS
1244Lung AbscessFAERS: 2US FAERS
1245Lymph node palpableFAERS: 2US FAERS
1246Lymphatic duct injuryFAERS: 2US FAERS
1247LymphoceleFAERS: 2US FAERS
1248Lymphocyte percentage increasedFAERS: 2US FAERS
1249MYELODYSPLASTIC SYNDROMEFAERS: 2US FAERS
1250MalabsorptionFAERS: 2US FAERS
1251Malignant melanoma of eyelidFAERS: 2US FAERS
1252Malignant neoplasm of thymusFAERS: 2US FAERS
1253Malignant tumour excisionFAERS: 2US FAERS
1254Maternal exposure during breast feedingFAERS: 2US FAERS
1255Maximum heart rate decreasedFAERS: 2US FAERS
1256Medical device complicationFAERS: 2US FAERS
1257Meibomian gland dysfunctionFAERS: 2US FAERS
1258MeibomianitisFAERS: 2US FAERS
1259Melanocytic hyperplasiaFAERS: 2US FAERS
1260Metabolic alkalosisFAERS: 2US FAERS
1261Micturition frequency decreasedFAERS: 2US FAERS
1262MiliariaFAERS: 2US FAERS
1263Milk AllergyFAERS: 2US FAERS
1264Miller Fisher SyndromeFAERS: 2US FAERS
1265Mite allergyFAERS: 2US FAERS
1266MoaningFAERS: 2US FAERS
1267Mole excisionFAERS: 2US FAERS
1268Morganella infectionFAERS: 2US FAERS
1269Myoglobin blood increasedFAERS: 2US FAERS
1270Natural killer cell count increasedFAERS: 2US FAERS
1271Occult blood positiveFAERS: 2US FAERS
1272Ocular vascular disorderFAERS: 2US FAERS
1273Optic nerve cuppingFAERS: 2US FAERS
1274OrchitisFAERS: 2US FAERS
1275Otitis ExternaFAERS: 2US FAERS
1276Overlap syndromeFAERS: 2US FAERS
1277PCO2 decreasedFAERS: 2US FAERS
1278Paternal exposure timing unspecifiedFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
1279Pathogen resistanceFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
1280Patient-device incompatibilityFAERS: 2US FAERS
1281Pelvic Inflammatory DiseaseFAERS: 2US FAERS
1282Pelvic abscessFAERS: 2US FAERS
1283Pelvic cystFAERS: 2US FAERS
1284Pelvic discomfortFAERS: 2US FAERS
1285Penoscrotal fusionFAERS: 2US FAERS
1286Pericardial CystFAERS: 2US FAERS
1287Peripheral nerve lesionFAERS: 2US FAERS
1288Peripheral venous diseaseFAERS: 2US FAERS
1289Perirectal abscessFAERS: 2US FAERS
1290Persistent depressive disorderFAERS: 2US FAERS
1291Physical disabilityFAERS: 2US FAERS
1292Pleural InfectionFAERS: 2US FAERS
1293PolyarthritisFAERS: 2US FAERS
1294PolyhydramniosFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
1295PorokeratosisFAERS: 2US FAERS
1296Post procedural sepsisFAERS: 2US FAERS
1297Poverty of speechFAERS: 2US FAERS
1298Pregnancy with contraceptive deviceFAERS: 2US FAERS
1299Premature EjaculationFAERS: 2US FAERS
1300Primary Biliary CholangitisFAERS: 2US FAERS
1301Procedural headacheFAERS: 2US FAERS
1302ProctocolitisFAERS: 2US FAERS
1303Product dose omissionFAERS: 2
Canada Vigilance: 3
Canada Vigilance
US FAERS
1304Product prescribing issueFAERS: 2US FAERS
1305PseudocystFAERS: 2US FAERS
1306PseudofolliculitisFAERS: 2US FAERS
1307PseudolymphomaFAERS: 2US FAERS
1308Pulmonary arterial hypertensionFAERS: 2US FAERS
1309Pulmonary granulomaFAERS: 2US FAERS
1310Punctate keratitisFAERS: 2US FAERS
1311Purulent dischargeFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
1312Rectal polypFAERS: 2US FAERS
1313Red cell distribution width decreasedFAERS: 2US FAERS
1314Renal cancer metastaticFAERS: 2US FAERS
1315Renal dysplasiaFAERS: 2US FAERS
1316Renal vein compressionFAERS: 2US FAERS
1317Retinal aneurysmFAERS: 2US FAERS
1318Retinal artery embolismFAERS: 2US FAERS
1319Retinal depositsFAERS: 2US FAERS
1320Retinal vascular thrombosisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
1321Retro-orbital neoplasmFAERS: 2US FAERS
1322RhinalgiaFAERS: 2US FAERS
1323Rouleaux formationFAERS: 2US FAERS
1324Rubella antibody positiveFAERS: 2US FAERS
1325SacroiliitisFAERS: 2US FAERS
1326SarcoidosisFAERS: 2US FAERS
1327SchizencephalyFAERS: 2US FAERS
1328Secondary hypertensionFAERS: 2US FAERS
1329Self-induced vomitingFAERS: 2US FAERS
1330SeminomaFAERS: 2US FAERS
1331Sense of oppressionFAERS: 2US FAERS
1332Sensitive skinFAERS: 2US FAERS
1333Sexual activity increasedFAERS: 2US FAERS
1334Simple Partial SeizuresFAERS: 2US FAERS
1335Single umbilical arteryFAERS: 2US FAERS
1336Skin texture abnormalFAERS: 2US FAERS
1337Sleep TalkingFAERS: 2US FAERS
1338SomnambulismFAERS: 2US FAERS
1339Spermatic cord funiculitisFAERS: 2US FAERS
1340Spitzoid melanomaFAERS: 2US FAERS
1341SpondylitisFAERS: 2US FAERS
1342Squamous cell carcinoma of pharynxFAERS: 2US FAERS
1343Staphylococcal abscessFAERS: 2US FAERS
1344StenosisFAERS: 2US FAERS
1345Stoma complicationFAERS: 2US FAERS
1346StridorFAERS: 2US FAERS
1347SubileusFAERS: 2US FAERS
1348Superinfection bacterialFAERS: 2US FAERS
1349T-lymphocyte count increasedFAERS: 2US FAERS
1350TeratomaFAERS: 2US FAERS
1351Testicular massFAERS: 2US FAERS
1352Therapeutic product ineffectiveFAERS: 2US FAERS
1353ThermohypoaesthesiaFAERS: 2US FAERS
1354Thirst decreasedFAERS: 2US FAERS
1355Thoracic Outlet SyndromeFAERS: 2US FAERS
1356ThymomaFAERS: 2US FAERS
1357Tinea CapitisFAERS: 2US FAERS
1358Tongue erythemaFAERS: 2US FAERS
1359Tooth ErosionFAERS: 2US FAERS
1360TorticollisFAERS: 2US FAERS
1361Total cholesterol/HDL ratio increasedFAERS: 2US FAERS
1362Toxic Shock SyndromeFAERS: 2US FAERS
1363Transaminases abnormalFAERS: 2US FAERS
1364Trendelenburg's symptomFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
1365Troponin T increasedFAERS: 2US FAERS
1366Ultrasound scan abnormalFAERS: 2US FAERS
1367Upper respiratory fungal infectionFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
1368Urinary sediment presentFAERS: 2US FAERS
1369Uterine PerforationFAERS: 2US FAERS
1370Uterine cervical metaplasiaFAERS: 2US FAERS
1371Vaginal relaxationFAERS: 2US FAERS
1372Vasculitic rashFAERS: 2US FAERS
1373Vein collapseFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
1374Venous InsufficiencyFAERS: 2US FAERS
1375Venous ThrombosisFAERS: 2US FAERS
1376Ventricular hyperkinesiaFAERS: 2US FAERS
1377Ventricular hypertrophyFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
1378Vertebral foraminal stenosisFAERS: 2US FAERS
1379Vertebral lesionFAERS: 2US FAERS
1380Viral pericarditisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
1381Vital functions abnormalFAERS: 2US FAERS
1382VitiligoFAERS: 2US FAERS
1383Vitreous degenerationFAERS: 2US FAERS
1384Wrong patient received medicationFAERS: 2US FAERS
1385XanthopsiaFAERS: 2US FAERS
1386pH urine decreasedFAERS: 2US FAERS
1387Abdominal sepsisFAERS: 1US FAERS
1388Aborted pregnancyFAERS: 1US FAERS
1389Acanthamoeba InfectionFAERS: 1US FAERS
1390Accidental deathFAERS: 1US FAERS
1391Accidental drug intake by childFAERS: 1US FAERS
1392Acid fast bacilli infectionFAERS: 1US FAERS
1393Acute zonal occult outer retinopathyFAERS: 1US FAERS
1394Adjusted calcium decreasedFAERS: 1US FAERS
1395Adnexa uteri painFAERS: 1US FAERS
1396AgoraphobiaFAERS: 1US FAERS
1397AgranulocytosisFAERS: 1US FAERS
1398AkinesiaFAERS: 1US FAERS
1399Alcohol abuseFAERS: 1US FAERS
1400Alcohol poisoningFAERS: 1US FAERS
1401Alcohol problemFAERS: 1US FAERS
1402AlexiaFAERS: 1US FAERS
1403Allergic coughFAERS: 1US FAERS
1404Allergic respiratory symptomFAERS: 1US FAERS
1405Allergy test positiveFAERS: 1US FAERS
1406Allergy to animalFAERS: 1US FAERS
1407Allergy to arthropod biteFAERS: 1US FAERS
1408Allergy to chemicalsFAERS: 1US FAERS
1409Allergy to synthetic fabricFAERS: 1US FAERS
1410AmeloblastomaFAERS: 1US FAERS
1411Ammonia increasedFAERS: 1US FAERS
1412Amniotic Band SyndromeFAERS: 1US FAERS
1413Anal FistulaFAERS: 1US FAERS
1414Anal sphincter atonyFAERS: 1US FAERS
1415Angiotensin converting enzyme increasedFAERS: 1US FAERS
1416Animal attackFAERS: 1US FAERS
1417AnisocytosisFAERS: 1US FAERS
1418AnisomastiaFAERS: 1US FAERS
1419Anorectal infectionFAERS: 1US FAERS
1420AnoxiaFAERS: 1US FAERS
1421Antibiotic resistant Staphylococcus testFAERS: 1US FAERS
1422Antigliadin antibody positiveFAERS: 1US FAERS
1423Antinuclear antibody increasedFAERS: 1US FAERS
1424Antiphospholipid SyndromeFAERS: 1US FAERS
1425Antiphospholipid antibodies positiveFAERS: 1US FAERS
1426Antipsychotic drug level increasedFAERS: 1US FAERS
1427Aplasia Cutis CongenitaFAERS: 1US FAERS
1428Application site burnFAERS: 1US FAERS
1429Application site woundFAERS: 1US FAERS
1430Arrhythmogenic Right Ventricular DysplasiaFAERS: 1US FAERS
1431Arterial InjuryFAERS: 1US FAERS
1432ArteritisFAERS: 1US FAERS
1433AsterixisFAERS: 1US FAERS
1434AstrocytomaFAERS: 1US FAERS
1435Atrial conduction time prolongationFAERS: 1US FAERS
1436Autoimmune thrombocytopeniaFAERS: 1US FAERS
1437Automatic bladderFAERS: 1US FAERS
1438B-cell lymphoma stage IVFAERS: 1US FAERS
1439B-lymphocyte count increasedFAERS: 1US FAERS
1440Behavioral addictionFAERS: 1US FAERS
1441Bell's phenomenonFAERS: 1US FAERS
1442Benign neoplasm of spinal cordFAERS: 1US FAERS
1443Beta 2 microglobulin increasedFAERS: 1US FAERS
1444Bifascicular blockFAERS: 1US FAERS
1445Biopsy bone marrow abnormalFAERS: 1US FAERS
1446Biopsy skin abnormalFAERS: 1US FAERS
1447Biopsy vulva abnormalFAERS: 1US FAERS
1448Bipolar I disorderFAERS: 1US FAERS
1449Bladder sphincter atonyFAERS: 1US FAERS
1450BlastomycosisFAERS: 1US FAERS
1451Blood 1,25-dihydroxycholecalciferol decreasedFAERS: 1US FAERS
1452Blood alkaline phosphatase abnormalFAERS: 1US FAERS
1453Blood bilirubin abnormalFAERS: 1US FAERS
1454Blood caffeine decreasedFAERS: 1US FAERS
1455Blood cholinesterase increasedFAERS: 1US FAERS
1456Blood creatine abnormalFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
1457Blood creatine phosphokinase MB increasedFAERS: 1US FAERS
1458Blood electrolytes decreasedFAERS: 1US FAERS
1459Blood erythropoietin decreasedFAERS: 1US FAERS
1460Blood folate increasedFAERS: 1US FAERS
1461Blood immunoglobulin A increasedFAERS: 1US FAERS
1462Blood immunoglobulin M increasedFAERS: 1US FAERS
1463Blood lactate dehydrogenase abnormalFAERS: 1US FAERS
1464Blood lactate dehydrogenase decreasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1465Blood pressure immeasurableFAERS: 1US FAERS
1466Blood pressure orthostatic abnormalFAERS: 1US FAERS
1467Blood triglycerides abnormalFAERS: 1US FAERS
1468Blood urea abnormalFAERS: 1US FAERS
1469Blue Toe SyndromeFAERS: 1US FAERS
1470Body TemperatureFAERS: 1US FAERS
1471Bone contusionFAERS: 1US FAERS
1472Bone density decreasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1473BoredomFAERS: 1US FAERS
1474Brain scan abnormalFAERS: 1US FAERS
1475Bronchial HyperreactivityFAERS: 1US FAERS
1476Bronchial ObstructionFAERS: 1US FAERS
1477BronchopneumopathyFAERS: 1US FAERS
1478Bronchopulmonary DysplasiaFAERS: 1US FAERS
1479Brown-Sequard SyndromeFAERS: 1US FAERS
1480Bullous impetigoFAERS: 1US FAERS
1481BunionFAERS: 1US FAERS
1482CD4 lymphocytes abnormalFAERS: 1US FAERS
1483CD4 lymphocytes increasedFAERS: 1US FAERS
1484CREST SyndromeFAERS: 1US FAERS
1485Calcification of muscleFAERS: 1US FAERS
1486Calcium deficiencyFAERS: 1US FAERS
1487Campylobacter colitisFAERS: 1US FAERS
1488CandidiasisFAERS: 1US FAERS
1489CandiduriaFAERS: 1US FAERS
1490Capillary FragilityFAERS: 1US FAERS
1491Carbon Monoxide PoisoningFAERS: 1US FAERS
1492Cardiac TamponadeFAERS: 1US FAERS
1493Cardiac function test abnormalFAERS: 1US FAERS
1494Cardiac valve ruptureFAERS: 1US FAERS
1495Cardiac ventricular disorderFAERS: 1US FAERS
1496Carotid artery aneurysmFAERS: 1US FAERS
1497CatarrhFAERS: 1US FAERS
1498CatatoniaFAERS: 1US FAERS
1499Catheter site thrombosisFAERS: 1US FAERS
1500Cavernous Sinus ThrombosisFAERS: 1US FAERS
1501Central nervous system function test abnormalFAERS: 1US FAERS
1502Central pain syndromeFAERS: 1US FAERS
1503Cerebellar HypoplasiaFAERS: 1US FAERS
1504Cerebellar dysplasiaFAERS: 1US FAERS
1505Cerebellar infarctionFAERS: 1US FAERS
1506Cerebral ArteriosclerosisFAERS: 1US FAERS
1507Cerebral hyperperfusion syndromeFAERS: 1US FAERS
1508Cerebral vasoconstrictionFAERS: 1US FAERS
1509Cerebrovascular stenosisFAERS: 1US FAERS
1510Cervical cord compressionFAERS: 1US FAERS
1511Cervical myelopathyFAERS: 1US FAERS
1512Cervicitis human papilloma virusFAERS: 1US FAERS
1513Cervicobrachial syndromeFAERS: 1US FAERS
1514Cervicogenic HeadacheFAERS: 1US FAERS
1515Cervix carcinoma recurrentFAERS: 1US FAERS
1516Cervix carcinoma stage IFAERS: 1US FAERS
1517Chlamydia test positiveFAERS: 1US FAERS
1518CholangiocarcinomaFAERS: 1US FAERS
1519ChondromalaciaFAERS: 1US FAERS
1520ChondrosarcomaFAERS: 1US FAERS
1521ChordomaFAERS: 1US FAERS
1522ChoreoathetosisFAERS: 1US FAERS
1523Chronic throat clearingFAERS: 1US FAERS
1524Clostridium test positiveFAERS: 1US FAERS
1525Coagulation time shortenedFAERS: 1US FAERS
1526CoccidioidomycosisFAERS: 1US FAERS
1527Cognitive linguistic deficitFAERS: 1US FAERS
1528Colonoscopy abnormalFAERS: 1US FAERS
1529Colposcopy abnormalFAERS: 1US FAERS
1530Combined immunodeficiencyFAERS: 1US FAERS
1531Complement factor C3 decreasedFAERS: 1US FAERS
1532Congenital cystic kidney diseaseFAERS: 1US FAERS
1533Congenital heart valve disorderFAERS: 1US FAERS
1534Congenital hypoparathyroidismFAERS: 1US FAERS
1535Congenital thrombocyte disorderFAERS: 1US FAERS
1536Consciousness fluctuatingFAERS: 1US FAERS
1537Contraindicated drug prescribedFAERS: 1US FAERS
1538Contrast media depositionFAERS: 1US FAERS
1539Conversion disorderFAERS: 1US FAERS
1540Corneal dystrophyFAERS: 1US FAERS
1541Corrective lens userFAERS: 1US FAERS
1542Cranial Nerve InfectionFAERS: 1US FAERS
1543Creutzfeldt-Jakob diseaseFAERS: 1US FAERS
1544Cryptococcus test positiveFAERS: 1US FAERS
1545Cutaneous lymphomaFAERS: 1US FAERS
1546Cutis LaxaFAERS: 1US FAERS
1547CyanopsiaFAERS: 1US FAERS
1548CyclitisFAERS: 1US FAERS
1549Cyclothymic DisorderFAERS: 1US FAERS
1550Cyst aspirationFAERS: 1US FAERS
1551CytopeniaFAERS: 1US FAERS
1552Dark circles under eyesFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1553Deafness NeurosensoryFAERS: 1US FAERS
1554DebridementFAERS: 1US FAERS
1555Deficiency of bile secretionFAERS: 1US FAERS
1556Delusional disorder, unspecified typeFAERS: 1US FAERS
1557DemodicidosisFAERS: 1US FAERS
1558Dental Restoration FailureFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1559Dermatofibrosarcoma ProtuberansFAERS: 1US FAERS
1560DermatofibrosarcomaFAERS: 1US FAERS
1561Device breakageFAERS: 1US FAERS
1562Dialysis related complicationFAERS: 1US FAERS
1563Differential white blood cell count abnormalFAERS: 1US FAERS
1564Diffuse alopeciaFAERS: 1US FAERS
1565Disease complicationFAERS: 1US FAERS
1566Disease susceptibilityFAERS: 1US FAERS
1567Disseminated Intravascular CoagulationFAERS: 1US FAERS
1568Dissociative Identity DisorderFAERS: 1US FAERS
1569Drug abuseFAERS: 1US FAERS
1570Drug dispensed to wrong patientFAERS: 1US FAERS
1571Drug level decreasedFAERS: 1US FAERS
1572Dural tearFAERS: 1US FAERS
1573DyspareuniaFAERS: 1US FAERS
1574Eczema HerpeticumFAERS: 1US FAERS
1575Electrocardiogram PQ interval prolongedFAERS: 1US FAERS
1576Electrocardiogram ST-T segment depressionFAERS: 1US FAERS
1577Electrocardiogram T wave amplitude increasedFAERS: 1US FAERS
1578Electrocardiogram U-wave abnormalityFAERS: 1US FAERS
1579Electrocardiogram delta waves abnormalFAERS: 1US FAERS
1580Embolic cerebral infarctionFAERS: 1US FAERS
1581Embolic strokeFAERS: 1US FAERS
1582EmpyemaFAERS: 1US FAERS
1583EncephalomalaciaFAERS: 1US FAERS
1584EnchondromaFAERS: 1US FAERS
1585EndocarditisFAERS: 1US FAERS
1586Endodontic procedureFAERS: 1US FAERS
1587EndometritisFAERS: 1US FAERS
1588Endotracheal intubation complicationFAERS: 1US FAERS
1589EnteritisFAERS: 1US FAERS
1590Enterococcus test positiveFAERS: 1US FAERS
1591EnthesopathyFAERS: 1US FAERS
1592EntropionFAERS: 1US FAERS
1593Enzyme abnormalityFAERS: 1US FAERS
1594EpendymomaFAERS: 1US FAERS
1595Epiglottis ulcerFAERS: 1US FAERS
1596EpiscleritisFAERS: 1US FAERS
1597Erdheim-Chester DiseaseFAERS: 1US FAERS
1598Erection increasedFAERS: 1US FAERS
1599EscharFAERS: 1US FAERS
1600Escherichia test positiveFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1601Ethmoid sinus surgeryFAERS: 1US FAERS
1602Exercise tolerance increasedFAERS: 1US FAERS
1603ExeresisFAERS: 1US FAERS
1604Exostosis of jawFAERS: 1US FAERS
1605Expanded disability status scale score decreasedFAERS: 1
Canada Vigilance: 5
Canada Vigilance
US FAERS
1606Exposure via body fluidFAERS: 1US FAERS
1607Exposure via breast milkFAERS: 1US FAERS
1608External ear painFAERS: 1US FAERS
1609Exudative retinopathyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1610Eye complication associated with deviceFAERS: 1US FAERS
1611Eye ulcerFAERS: 1US FAERS
1612Eyeglasses therapyFAERS: 1US FAERS
1613Eyelid dermatochalasisFAERS: 1US FAERS
1614Eyelid skin drynessFAERS: 1US FAERS
1615Factor V deficiencyFAERS: 1US FAERS
1616Failure to ThriveFAERS: 1US FAERS
1617FasciitisFAERS: 1US FAERS
1618Female sex hormone level abnormalFAERS: 1US FAERS
1619Fine motor delayFAERS: 1US FAERS
1620Flat affectFAERS: 1US FAERS
1621Focal Nodular HyperplasiaFAERS: 1US FAERS
1622Food aversionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1623Forced expiratory volume abnormalFAERS: 1US FAERS
1624Fracture painFAERS: 1US FAERS
1625Functional residual capacity abnormalFAERS: 1US FAERS
1626Gadolinium deposition diseaseFAERS: 1US FAERS
1627Gallbladder adenocarcinomaFAERS: 1US FAERS
1628Gastric BypassFAERS: 1US FAERS
1629Gastric DilatationFAERS: 1US FAERS
1630Gastric FistulaFAERS: 1US FAERS
1631Gastroenteritis norovirusFAERS: 1US FAERS
1632Gastrointestinal bacterial infectionFAERS: 1US FAERS
1633Gastrointestinal bacterial overgrowthFAERS: 1US FAERS
1634Gastrointestinal hypomotilityFAERS: 1US FAERS
1635Gastrointestinal lymphomaFAERS: 1US FAERS
1636Gastrointestinal stromal cancerFAERS: 1US FAERS
1637Gastrointestinal tract adenomaFAERS: 1US FAERS
1638Genital herpes zosterFAERS: 1US FAERS
1639Gingival HypertrophyFAERS: 1US FAERS
1640Gingival erythemaFAERS: 1US FAERS
1641Glioblastoma MultiformeFAERS: 1US FAERS
1642Gliomatosis cerebriFAERS: 1US FAERS
1643Glossopharyngeal NeuralgiaFAERS: 1US FAERS
1644Granulocyte count decreasedFAERS: 1US FAERS
1645Granuloma AnnulareFAERS: 1US FAERS
1646Granulomatosis with polyangiitisFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
1647Granulomatous liver diseaseFAERS: 1US FAERS
1648Growing painsFAERS: 1US FAERS
1649Growth retardationFAERS: 1US FAERS
1650HELLP SyndromeFAERS: 1US FAERS
1651HER-2 positive breast cancerFAERS: 1US FAERS
1652Hair injuryFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1653Hemisensory NeglectFAERS: 1US FAERS
1654Hepatitis A virus test positiveFAERS: 1US FAERS
1655Hepatitis C virus test positiveFAERS: 1US FAERS
1656Hepatitis EFAERS: 1US FAERS
1657Hepatobiliary cancerFAERS: 1US FAERS
1658HepatosplenomegalyFAERS: 1US FAERS
1659Hernia painFAERS: 1US FAERS
1660Herpes pharyngitisFAERS: 1US FAERS
1661Herpes simplex serologyFAERS: 1US FAERS
1662Herpes simplex test positiveFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1663Herpes zoster meningomyelitisFAERS: 1US FAERS
1664High density lipoprotein abnormalFAERS: 1US FAERS
1665Hodgkin's disease nodular sclerosis stage IVFAERS: 1US FAERS
1666HypermetabolismFAERS: 1US FAERS
1667HypersplenismFAERS: 1US FAERS
1668Hypertensive emergencyFAERS: 1US FAERS
1669HypervigilanceFAERS: 1US FAERS
1670Hypoaesthesia facialFAERS: 1US FAERS
1671Hypoglossal nerve paralysisFAERS: 1US FAERS
1672Hypoglossal nerve paresisFAERS: 1US FAERS
1673HypoperfusionFAERS: 1US FAERS
1674HyposideraemiaFAERS: 1US FAERS
1675HysterectomyFAERS: 1US FAERS
1676Idiopathic urticariaFAERS: 1US FAERS
1677Idiosyncratic drug reactionFAERS: 1US FAERS
1678Immature respiratory systemFAERS: 1US FAERS
1679Impaired reasoningFAERS: 1US FAERS
1680Impaired self-careFAERS: 1US FAERS
1681Incision site painFAERS: 1US FAERS
1682Incorrect route of product administrationFAERS: 1US FAERS
1683Increased viscosity of upper respiratory secretionFAERS: 1US FAERS
1684Infantile apnoeic attackFAERS: 1US FAERS
1685Infection in an immunocompromised hostFAERS: 1US FAERS
1686Infectious colitisFAERS: 1US FAERS
1687Infectious pleural effusionFAERS: 1US FAERS
1688Infective glossitisFAERS: 1US FAERS
1689Injection site abscessFAERS: 1US FAERS
1690Injection site massFAERS: 1US FAERS
1691Injection site urticariaFAERS: 1US FAERS
1692Inspiratory capacity decreasedFAERS: 1US FAERS
1693Intellectual DisabilityFAERS: 1US FAERS
1694Intentional dose omissionFAERS: 1US FAERS
1695Intentional drug misuseFAERS: 1US FAERS
1696Intercepted drug dispensing errorFAERS: 1US FAERS
1697Intercostal neuralgiaFAERS: 1US FAERS
1698Interleukin level increasedFAERS: 1US FAERS
1699Intestinal metastasisFAERS: 1US FAERS
1700IsosporiasisFAERS: 1US FAERS
1701Joint vibrationFAERS: 1US FAERS
1702Klebsiella test positiveFAERS: 1US FAERS
1703Knuckle padsFAERS: 1US FAERS
1704LDL/HDL ratio decreasedFAERS: 1US FAERS
1705Labile hypertensionFAERS: 1US FAERS
1706Laboratory test interferenceFAERS: 1US FAERS
1707Lack of satietyFAERS: 1US FAERS
1708LeukoencephalopathyFAERS: 1US FAERS
1709Leukopenia neonatalFAERS: 1US FAERS
1710Libido disorderFAERS: 1US FAERS
1711Lid sulcus deepenedFAERS: 1US FAERS
1712Ligament painFAERS: 1US FAERS
1713Light chain analysisFAERS: 1US FAERS
1714Light chain analysis increasedFAERS: 1US FAERS
1715Lip InfectionFAERS: 1US FAERS
1716Lip erythemaFAERS: 1US FAERS
1717Lipoma of breastFAERS: 1US FAERS
1718LissencephalyFAERS: 1US FAERS
1719LithiasisFAERS: 1US FAERS
1720Liver AbscessFAERS: 1US FAERS
1721Lobar PneumoniaFAERS: 1US FAERS
1722LordosisFAERS: 1US FAERS
1723Loss of bladder sensationFAERS: 1US FAERS
1724Low density lipoprotein abnormalFAERS: 1US FAERS
1725Lower respiratory tract congestionFAERS: 1US FAERS
1726Lower respiratory tract infection viralFAERS: 1US FAERS
1727Lumbar puncture abnormalFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1728Lumbosacral plexopathyFAERS: 1US FAERS
1729Lymphadenitis bacterialFAERS: 1US FAERS
1730Lymphoplasmacytoid lymphoma/immunocytomaFAERS: 1US FAERS
1731Macular reflex abnormalFAERS: 1US FAERS
1732Macular ruptureFAERS: 1US FAERS
1733Malignant Atrophic PapulosisFAERS: 1US FAERS
1734Malignant HypertensionFAERS: 1US FAERS
1735Malignant ascitesFAERS: 1US FAERS
1736Malignant melanoma stage IIFAERS: 1US FAERS
1737Malignant melanoma stage IVFAERS: 1US FAERS
1738Malignant neoplasm of thoraxFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1739Mantle cell lymphomaFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
1740MastoiditisFAERS: 1US FAERS
1741Maternal exposure during deliveryFAERS: 1US FAERS
1742May-Thurner SyndromeFAERS: 1US FAERS
1743Measles antibody positiveFAERS: 1US FAERS
1744Mechanical ventilationFAERS: 1US FAERS
1745Mediastinal massFAERS: 1US FAERS
1746MegacolonFAERS: 1US FAERS
1747MelanosisFAERS: 1US FAERS
1748MeningismFAERS: 1US FAERS
1749Meningitis herpesFAERS: 1US FAERS
1750MeningoradiculitisFAERS: 1US FAERS
1751MeningorrhagiaFAERS: 1US FAERS
1752Mental disorder due to a general medical conditionFAERS: 1US FAERS
1753Metamyelocyte count increasedFAERS: 1US FAERS
1754Metapneumovirus infectionFAERS: 1US FAERS
1755Metastases to abdominal cavityFAERS: 1US FAERS
1756Metastatic NeoplasmFAERS: 1US FAERS
1757Metastatic Renal Cell CarcinomaFAERS: 1US FAERS
1758Morning SicknessFAERS: 1US FAERS
1759MosaicismFAERS: 1US FAERS
1760Mouth BreathingFAERS: 1US FAERS
1761Mucoepidermoid CarcinomaFAERS: 1US FAERS
1762Multiple allergiesFAERS: 1US FAERS
1763Multiple sclerosis plaqueFAERS: 1US FAERS
1764Muscle necrosisFAERS: 1US FAERS
1765Muscle tone disorderFAERS: 1US FAERS
1766Muscular DystrophyFAERS: 1US FAERS
1767Mycobacterium marinum InfectionFAERS: 1US FAERS
1768Mycoplasma test positiveFAERS: 1US FAERS
1769Mycosis fungoides stage IIFAERS: 1US FAERS
1770Mycotic allergyFAERS: 1US FAERS
1771Myeloblast count increasedFAERS: 1US FAERS
1772Myelocyte count increasedFAERS: 1US FAERS
1773Myocardial necrosis marker increasedFAERS: 1US FAERS
1774Myoclonic EpilepsyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1775MyopathyFAERS: 1US FAERS
1776Nail bed disorderFAERS: 1US FAERS
1777Nail bed infection bacterialFAERS: 1US FAERS
1778Nasal mucosal erosionFAERS: 1US FAERS
1779Nasal pruritusFAERS: 1US FAERS
1780Natural killer T cell count decreasedFAERS: 1US FAERS
1781NecrosisFAERS: 125939952CTD
US FAERS
1782Neonatal disorderFAERS: 1US FAERS
1783Neonatal infectionFAERS: 1US FAERS
1784NephritisFAERS: 1US FAERS
1785Nerve Root CompressionFAERS: 1US FAERS
1786Nerve stimulation test abnormalFAERS: 1US FAERS
1787Neuralgic AmyotrophyFAERS: 1US FAERS
1788NeurocryptococcosisFAERS: 1US FAERS
1789Neurogenic BowelFAERS: 1US FAERS
1790Neurological examination abnormalFAERS: 1US FAERS
1791Neutropenic sepsisFAERS: 1US FAERS
1792Neutrophil count abnormalFAERS: 1US FAERS
1793Neutrophilic dermatosisFAERS: 1US FAERS
1794No reaction on previous exposure to drugFAERS: 1US FAERS
1795Nodular melanomaFAERS: 1US FAERS
1796Non-small cell lung cancer stage IFAERS: 1US FAERS
1797Noninfective gingivitisFAERS: 1US FAERS
1798Noninfective sialoadenitisFAERS: 1US FAERS
1799Nuclear magnetic resonance imaging spinal abnormalFAERS: 1US FAERS
1800OligohydramniosFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1801Omental necrosisFAERS: 1US FAERS
1802OpisthotonusFAERS: 1US FAERS
1803Oral mucosal erythemaFAERS: 1US FAERS
1804Oral pustuleFAERS: 1US FAERS
1805Oropharyngeal swellingFAERS: 1US FAERS
1806Orthosis userFAERS: 1US FAERS
1807Orthostatic hypertensionFAERS: 1US FAERS
1808OsteochondrosisFAERS: 1US FAERS
1809OsteolysisFAERS: 1US FAERS
1810OsteosarcomaFAERS: 1US FAERS
1811Ovarian cancer stage IVFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1812Ovarian cyst torsionFAERS: 1US FAERS
1813POEMS SyndromeFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1814PachymeningitisFAERS: 1US FAERS
1815Palmar erythemaFAERS: 1US FAERS
1816Pancreatic CystFAERS: 1US FAERS
1817Pancreatic NeoplasmFAERS: 1US FAERS
1818Pancreatic PseudocystFAERS: 1US FAERS
1819Pancreatic duct obstructionFAERS: 1US FAERS
1820PanniculitisFAERS: 1US FAERS
1821Paranasal cystFAERS: 1US FAERS
1822Paranasal sinus mucosal hypertrophyFAERS: 1US FAERS
1823Patent ductus arteriosusFAERS: 1US FAERS
1824Pathological fractureFAERS: 1US FAERS
1825Pelvic InfectionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1826Pelvic fluid collectionFAERS: 1US FAERS
1827PemphigusFAERS: 1US FAERS
1828Perforated ulcerFAERS: 1US FAERS
1829Perineal painFAERS: 1US FAERS
1830Perineal ulcerationFAERS: 1US FAERS
1831PeriodontitisFAERS: 1US FAERS
1832Periorbital InfectionFAERS: 1US FAERS
1833Periorbital contusionFAERS: 1US FAERS
1834Peripheral arterial occlusive diseaseFAERS: 1SIDER
US FAERS
1835Peripheral arthritisFAERS: 1US FAERS
1836Peripheral embolismFAERS: 1US FAERS
1837Peripheral nerve paresisFAERS: 1US FAERS
1838Pituitary cystFAERS: 1US FAERS
1839Platelet aggregation inhibitionFAERS: 1US FAERS
1840Platelet distribution width increasedFAERS: 1US FAERS
1841Pleuritic painFAERS: 1US FAERS
1842PleuropericarditisFAERS: 1US FAERS
1843PneumoperitoneumFAERS: 1US FAERS
1844PoikilocytosisFAERS: 1US FAERS
1845Polymyalgia RheumaticaFAERS: 1US FAERS
1846Polyomavirus test positiveFAERS: 1US FAERS
1847Polyomavirus-associated nephropathyFAERS: 1US FAERS
1848Poor quality drug administeredFAERS: 1US FAERS
1849Porphyria non-acuteFAERS: 1US FAERS
1850Portal vein dilatationFAERS: 1US FAERS
1851Post procedural contusionFAERS: 1US FAERS
1852Post procedural myocardial infarctionFAERS: 1US FAERS
1853Posterior fossa syndromeFAERS: 1US FAERS
1854Pregnancy on contraceptiveFAERS: 1US FAERS
1855Pregnancy test positiveFAERS: 1US FAERS
1856PrehypertensionFAERS: 1US FAERS
1857Premature MenopauseFAERS: 1US FAERS
1858Premenstrual syndromeFAERS: 1US FAERS
1859Prerenal failureFAERS: 1US FAERS
1860Prescription drug used without a prescriptionFAERS: 1US FAERS
1861Presenile dementiaFAERS: 1US FAERS
1862PriapismFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
1863Procalcitonin increasedFAERS: 1US FAERS
1864Procedural site reactionFAERS: 1US FAERS
1865Proctitis infectiousFAERS: 1US FAERS
1866ProctitisFAERS: 1US FAERS
1867Product closure issueFAERS: 1US FAERS
1868Product contamination physicalFAERS: 1US FAERS
1869Product intoleranceFAERS: 1US FAERS
1870ProlactinomaFAERS: 1US FAERS
1871ProsopagnosiaFAERS: 1US FAERS
1872ProteinuriaFAERS: 115680492CTD
US FAERS
1873Pruritus allergicFAERS: 1US FAERS
1874PseudodementiaFAERS: 1US FAERS
1875Pseudoneurologic symptomFAERS: 1US FAERS
1876Psychogenic movement disorderFAERS: 1US FAERS
1877Pupillary light reflex tests abnormalFAERS: 1US FAERS
1878PurulenceFAERS: 1US FAERS
1879Pyoderma GangrenosumFAERS: 1US FAERS
1880QuadranopiaFAERS: 1US FAERS
1881Radial nerve compressionFAERS: 1US FAERS
1882Radial pulse decreasedFAERS: 1US FAERS
1883Radiation associated painFAERS: 1US FAERS
1884Radiation skin injuryFAERS: 1US FAERS
1885Radical hysterectomyFAERS: 1US FAERS
1886RadiculitisFAERS: 1US FAERS
1887Radiologically isolated syndromeFAERS: 1US FAERS
1888RalesFAERS: 1US FAERS
1889Reaction to drug excipientsFAERS: 1US FAERS
1890Reaction to food additiveFAERS: 1US FAERS
1891Rectal abscessFAERS: 1US FAERS
1892Rectal tenesmusFAERS: 1US FAERS
1893RectoceleFAERS: 1US FAERS
1894Red blood cell morphology abnormalFAERS: 1US FAERS
1895Renal Artery StenosisFAERS: 1US FAERS
1896Renal abscessFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1897Respiratory arrestFAERS: 1US FAERS
1898Respiratory fume inhalation disorderFAERS: 1US FAERS
1899Respiratory muscle weaknessFAERS: 1US FAERS
1900Retention cystFAERS: 1US FAERS
1901Retinal Artery OcclusionFAERS: 1US FAERS
1902Retinal depigmentationFAERS: 1US FAERS
1903Retinal pallorFAERS: 1US FAERS
1904Retinal pigment epitheliopathyFAERS: 1US FAERS
1905Retinal pigmentationFAERS: 1US FAERS
1906Retinal scarFAERS: 1US FAERS
1907RhabdomyolysisFAERS: 1US FAERS
1908Rheumatic FeverFAERS: 1US FAERS
1909Rheumatoid factor increasedFAERS: 1US FAERS
1910RhinolaryngitisFAERS: 1US FAERS
1911Right Ventricular HypertrophyFAERS: 1US FAERS
1912Right atrial dilatationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1913Right hemisphere deficit syndromeFAERS: 1US FAERS
1914Root canal infectionFAERS: 1US FAERS
1915Salt cravingFAERS: 1US FAERS
1916Sarcoma of skinFAERS: 1US FAERS
1917SarcomatosisFAERS: 1US FAERS
1918Schirmer's test abnormalFAERS: 1US FAERS
1919Schizoaffective DisorderFAERS: 1US FAERS
1920SchizophreniaFAERS: 1US FAERS
1921Sebaceous adenomaFAERS: 1US FAERS
1922Sensory processing disorderFAERS: 1US FAERS
1923SeromaFAERS: 1US FAERS
1924ShockFAERS: 1US FAERS
1925Shoulder deformityFAERS: 1US FAERS
1926Shunt malfunctionFAERS: 1US FAERS
1927Shunt occlusionFAERS: 1US FAERS
1928Sinus operationFAERS: 1US FAERS
1929Skeletal injuryFAERS: 1US FAERS
1930Skin IndurationFAERS: 1US FAERS
1931Skin WrinklingFAERS: 1US FAERS
1932Skin discomfortFAERS: 1US FAERS
1933Skin hypertrophyFAERS: 1US FAERS
1934Skin indentationFAERS: 1US FAERS
1935Skin necrosisFAERS: 1US FAERS
1936Skin weepingFAERS: 1US FAERS
1937Sleep ParalysisFAERS: 1US FAERS
1938Soft Tissue InfectionFAERS: 1US FAERS
1939Soft tissue necrosisFAERS: 1US FAERS
1940SoliloquyFAERS: 1US FAERS
1941Somatic symptom disorderFAERS: 1US FAERS
1942SoporFAERS: 1US FAERS
1943Spina BifidaFAERS: 1US FAERS
1944Spinal Muscular AtrophyFAERS: 1US FAERS
1945Spinal StenosisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1946Spinal cord herniationFAERS: 1US FAERS
1947Splenic InfarctionFAERS: 1US FAERS
1948SpondylolisthesisFAERS: 1US FAERS
1949Sputum retentionFAERS: 1US FAERS
1950SteatohepatitisFAERS: 1US FAERS
1951Streptococcal abscessFAERS: 1US FAERS
1952Sudden Cardiac DeathFAERS: 1US FAERS
1953Sudden deathFAERS: 1US FAERS
1954Suicide threatFAERS: 1US FAERS
1955SyndactylyFAERS: 1US FAERS
1956SynovitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1957SyringomyeliaFAERS: 1US FAERS
1958Systemic Inflammatory Response SyndromeFAERS: 1US FAERS
1959Systemic lupus erythematosus rashFAERS: 1US FAERS
1960Systemic mycosisFAERS: 1US FAERS
1961Systolic dysfunctionFAERS: 1US FAERS
1962T-Cell LymphomaFAERS: 1US FAERS
1963T-cell lymphoma recurrentFAERS: 1US FAERS
1964Temperature difference of extremitiesFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1965Terminal stateFAERS: 1US FAERS
1966Testicular seminoma (pure) stage IFAERS: 1US FAERS
1967TetanyFAERS: 1US FAERS
1968Therapeutic response changedFAERS: 1US FAERS
1969Therapeutic response delayedFAERS: 1US FAERS
1970ThrombophlebitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1971Thyroglobulin increasedFAERS: 1US FAERS
1972Thyroid atrophyFAERS: 1US FAERS
1973Thyroid hormones increasedFAERS: 1US FAERS
1974Tick ParalysisFAERS: 1US FAERS
1975Time perception alteredFAERS: 1US FAERS
1976Tissue irritationFAERS: 1US FAERS
1977Tissue ruptureFAERS: 1US FAERS
1978Tongue eruptionFAERS: 1US FAERS
1979Tongue exfoliationFAERS: 1US FAERS
1980Tongue movement disturbanceFAERS: 1US FAERS
1981Tooth ExtractionFAERS: 1US FAERS
1982ToxoplasmosisFAERS: 1US FAERS
1983Transaminases decreasedFAERS: 1US FAERS
1984Traumatic liver injuryFAERS: 1SIDER
US FAERS
1985Traumatic renal injuryFAERS: 1US FAERS
1986Trifascicular blockFAERS: 1US FAERS
1987Tubular breast carcinomaFAERS: 1US FAERS
1988Tumour haemorrhageFAERS: 1US FAERS
1989Ultrasound pelvis abnormalFAERS: 1US FAERS
1990Urethral ObstructionFAERS: 1US FAERS
1991Urethral StenosisFAERS: 1US FAERS
1992Urethral dischargeFAERS: 1US FAERS
1993Urethral perforationFAERS: 1US FAERS
1994Urethral spasmFAERS: 1US FAERS
1995UrethritisFAERS: 1US FAERS
1996Urinary tract infection staphylococcalFAERS: 1US FAERS
1997Urine output increasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1998Urticarial vasculitisFAERS: 1US FAERS
1999Uterine RuptureFAERS: 1US FAERS
2000Uterine inflammationFAERS: 1US FAERS
2001Uterine spasmFAERS: 1US FAERS
2002VIth nerve paresisFAERS: 1US FAERS
2003Vaccination errorFAERS: 1US FAERS
2004Vaginal FistulaFAERS: 1US FAERS
2005Vaginal mucosal blisteringFAERS: 1US FAERS
2006VaricoceleFAERS: 1US FAERS
2007Vascular encephalopathyFAERS: 1US FAERS
2008Venous InjuryFAERS: 1US FAERS
2009Venous angioma of brainFAERS: 1US FAERS
2010Ventricular parasystoleFAERS: 1US FAERS
2011Vertebral Artery StenosisFAERS: 1US FAERS
2012Vertebral artery hypoplasiaFAERS: 1US FAERS
2013Vertebral artery thrombosisFAERS: 1US FAERS
2014Vertebrobasilar InsufficiencyFAERS: 1US FAERS
2015Viral rhinitisFAERS: 1US FAERS
2016Visual acuity reduced transientlyFAERS: 1US FAERS
2017Vitreous lossFAERS: 1US FAERS
2018Vocal Cord ParalysisFAERS: 1US FAERS
2019Von Willebrand's factor antigen decreasedFAERS: 1US FAERS
2020Vulvovaginal drynessFAERS: 1US FAERS
2021Vulvovaginal swellingFAERS: 1US FAERS
2022Vulvovaginal wartsFAERS: 1US FAERS
2023VulvovaginitisFAERS: 1US FAERS
2024White blood cell morphology abnormalFAERS: 1US FAERS
2025Wound dehiscenceFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
2026Wound infection staphylococcalFAERS: 1US FAERS
2027Wrong product administeredFAERS: 1US FAERS
2028XerodermaFAERS: 1US FAERS
2029Zinc deficiencyFAERS: 1US FAERS
2030gallbladder neoplasmFAERS: 1US FAERS
2031keratoacanthomaFAERS: 1US FAERS
2032neurofibromaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
2033ovarian neoplasmFAERS: 1US FAERS
2034Acute Lung Injury24893116CTD
2035Atherosclerosis20056921CTD
2036Blood 25-hydroxycholecalciferol decreasedCanada Vigilance: 1Canada Vigilance
2037Blood and lymphatic system disordersSIDER
2038Blood bilirubin unconjugated increasedCanada Vigilance: 1Canada Vigilance
2039Body temperature fluctuationCanada Vigilance: 1Canada Vigilance
2040Cartilage injuryCanada Vigilance: 1Canada Vigilance
2041Croup infectiousCanada Vigilance: 1Canada Vigilance
2042Glomerulonephritis15680492CTD
2043Herpes NOSSIDER
2044HirsutismCanada Vigilance: 2Canada Vigilance
2045Histiocytosis haematophagicSIDER
2046Infarction, Middle Cerebral Artery23043544CTD
2047Infection reactivationCanada Vigilance: 1Canada Vigilance
2048InfestationSIDER
2049Influenza viral infectionsSIDER
2050Injection site necrosisCanada Vigilance: 1Canada Vigilance
2051LigamentitisCanada Vigilance: 1Canada Vigilance
2052Lumbar herniaCanada Vigilance: 1Canada Vigilance
2053Multiple Sclerosis, Relapsing-Remitting24859201
26719367
CTD
2054Neoplasm Invasiveness25980589CTD
2055Neural Tube Defects26719367CTD
2056Oral pruritusCanada Vigilance: 1Canada Vigilance
2057Pilonidal CystCanada Vigilance: 1Canada Vigilance
2058Procedural nauseaCanada Vigilance: 1Canada Vigilance
2059Product administration errorCanada Vigilance: 1Canada Vigilance
2060Product complaintCanada Vigilance: 2Canada Vigilance
2061Pulmonary painCanada Vigilance: 1Canada Vigilance
2062Seasonal Affective DisorderCanada Vigilance: 1Canada Vigilance
2063Septic arthritis streptococcalCanada Vigilance: 1Canada Vigilance
2064Staphylococcal pharyngitisCanada Vigilance: 1Canada Vigilance
2065Sudden onset of sleepCanada Vigilance: 1Canada Vigilance
2066Swelling of eyelidCanada Vigilance: 2Canada Vigilance
2067Systolic hypertensionCanada Vigilance: 1Canada Vigilance
2068Urinary bladder abscessCanada Vigilance: 1Canada Vigilance
2069Varicella zosterSIDER
2070Wrong doseCanada Vigilance: 2Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.